Estudo do mecanismo molecular envolvido na retenção de esperozoítos de Plasmodium nos sinusoides hepáticos by Sá, Mónica da Silva
 Universidade de Aveiro 
Ano 2016  
Departamento de Biologia 
Mónica  
da Silva Sá 
 
Estudo do mecanismo molecular envolvido na 
retenção de esporozoítos de Plasmodium nos 
sinusoides hepáticos  
 
Dissecting the molecular basis for the arrest of 
Plasmodium sporozoites in the liver sinusoids  
 
 
 
 
   
 
iii 
 
 
 
DECLARAÇÃO 
Declaro que este relatório é integralmente da minha autoria, 
estando devidamente referenciadas as fontes e obras 
consultadas, bem como identificadas de modo claro as citações 
dessas obras. Não contém, por isso, qualquer tipo de plágio quer 
de textos publicados, qualquer que seja o meio dessa 
publicação, incluindo meios eletrónicos, quer de trabalhos 
académicos. 
  
  
Universidade de Aveiro 
Ano 2016  
Departamento de Biologia 
Mónica 
da Silva Sá 
 
 
Estudo do mecanismo molecular envolvido na 
retenção de esporozoítos de Plasmodium nos 
sinusoides hepáticos  
 
Dissecting the molecular basis for the arrest of 
Plasmodium sporozoites in the liver sinusoids  
 
 Dissertação apresentada à Universidade de Aveiro para cumprimento dos 
requisitos necessários à obtenção do grau de Mestre em Microbiologia, 
realizada sob a orientação científica da Doutora Joana Alexandra Pinto da 
Costa Tavares, Investigadora Auxiliar, Instituto de Biologia Molecular e Celular/ 
Instituto de Investigação e Inovação em Saúde da Universidade do Porto, da 
Professora Doutora Anabela Cordeiro-da-Silva, Professora Associada com 
Agregação, Faculdade de Farmácia da Universidade do Porto e da Professora 
Doutora Maria de Fátima Matos Almeida Henriques de Macedo, Professora 
Auxiliar Convidada do Departamento de Ciências Médicas da Universidade de 
Aveiro. 
 
  A investigação conducente à obtenção destes resultados foi financiada pela 
Fundação para a Ciência e Tecnologia (FCT)/ Ministério da Educação e 
Ciência (MEC) cofinanciada pelo FEDER através dos projetos: 
EXPL/JTavares-IF/00881/2012/CP0158; EXPL/IMI-MIC/1331/2013 e Unidade 
de Investigação No. 4293. Este trabalho recebeu também financiamento do 
projeto Norte-01-0145-FEDER-000012, suportado pelo NORTE 2020, através 
do PORTUGAL 2020, FEDER. 
 
 
  
vii 
 
 
  
  
 
 
 
Aos meus Pais e às minhas Avós. 
 
 
 
  
ix 
 
  
 
 
 
 
 
 
o júri   
 
presidente Doutora Isabel da Silva Henriques 
equiparada e investigadora auxiliar, Universidade de Aveiro. 
  
 
 Doutora Inês Marina Soares Loureiro 
investigadora de pós doutoramento, Instituto de Biologia Molecular e Celular/ Instituto de 
Investigação e Inovação em Saúde da Universidade do Porto. 
  
 
 Doutora Joana Alexandra Pinto da Costa Tavares 
investigadora auxiliar, Instituto de Biologia Molecular e Celular/ Instituto de Investigação e 
Inovação em Saúde da Universidade do Porto. 
  
 
 
 
 
  
xi 
 
 
  
  
 
agradecimentos 
 
Em primeiro lugar, gostaria de agradecer à Doutora Joana Tavares pela 
confiança que depositou em mim desde o primeiro dia, por todo o seu 
incansável apoio e por me ter guiado e aconselhado durante a minha primeira 
aventura pelo mundo da Ciência. Todo este trabalho se deve a si. Muito 
Obrigado. 
  
À Professora Anabela por me ter acolhido tão bem no seu grupo, e por me ter 
dado a fantástica oportunidade de participar em projetos fora do âmbito da 
minha dissertação, fornecendo-me todos os meios para que eu pudesse 
aprofundar os meus conhecimentos teóricos e práticos no que concerne a 
purificação de proteínas e ensaios enzimáticos.  
 
À Professora Fátima Macedo, por se ter demonstrado sempre disponível 
durante este percurso.   
 
Ao David. Acho não tenho palavras suficientes para te agradecer, mas aqui vai 
a minha tentativa: muito obrigado por NUNCA me teres recusado ajuda, por 
toda a (infinita!) paciência que tiveste comigo e por todas as conversas que 
tivemos (mesmo por vezes fora de horas). Este trabalho também é teu. 
 
Aos restantes membros do grupo por me terem feito sentir em casa. Passar 
um ano convosco foi deveras uma experiência única :)  
 
À Carla, Sara e ao Gustavo, por nunca me terem deixado de apoiar e por me 
fazerem sempre ver o lado B da vida.  
 
Aos meus pais e avós, por serem o meu maior suporte. Este trabalho é para 
vocês.  
 
E por fim, a ti Miguel, por todo o carinho e apoio que me deste durante este 
percurso, por nunca me teres falhado, e acima de tudo, por nunca teres 
deixado de acreditar em mim.  
 
 
 
 
  
 
xiii 
 
  
 
 
 
 
 
 
 
 
 
 
  
palavras-chave 
 
Malaria, Plasmodium, esporozoíto, fase pré-eritrocitária, imagem em tempo 
real, TRAP, MAEBL  
resumo 
 
 
A malária é uma doença grave causada por parasitas do género Plasmodium e 
transmitida a mamíferos através da picada de um mosquito fêmea infetado do 
género Anopheles. A fase pré-eritrocitária do ciclo de vida dos parasitas é 
assintomática, englobando o percurso dos esporozoítos desde a pele até ao 
fígado, a sua multiplicação dentro de hepatócitos e libertação de merozoitos, 
as formas responsáveis pela infeção de eritrócitos. Uma etapa crucial para a 
infeção do fígado pelos esporozoítos envolve a retenção dos mesmos nos 
sinusoides. A proteína “thrombospondin-related adhesion protein” (TRAP) é a 
uma molécula candidata para a mediação deste evento, uma vez que 
esporozoítos “knockout” da TRAP não ficam retidos no fígado. Contudo, esta 
proteína possui uma estrutura complexa composta por domínios adesivos na 
sua porção extracelular, para além de estar ligada ao motor de actina-miosina 
do esporozoíto através do domínio citoplasmático em C terminal. Assim, de 
modo a explorar o papel da TRAP como mediador da retenção de 
esporozoítos no fígado, construímos parasitas bioluminescentes capazes de 
expressar a TRAP sem a cauda citoplasmática, uma vez que a deleção deste 
domínio torna os parasitas imóveis mas não altera a apresentação da proteína 
à superfície do esporozoíto. Como estes parasitas não conseguem invadir as 
glândulas salivares dos mosquitos e portanto maturarem completamente, 
criamos “knockouts” da maebl como controlo, uma vez que com base na 
literatura estes permanecem na hemolinfa de mosquitos mas infetam 
normalmente o fígado. Surpreendentemente, descobrimos que esporozoítos 
“knockout” da maebl têm um defeito na retenção hepática e consequentemente 
na capacidade de infetarem o fígado. Adicionalmente estudos in vitro 
demonstraram que os esporozoítos knockout da maebl têm um defeito na 
capacidade de atravessarem e invadirem hepatócitos. Com base nestes 
resultados, sugerimos que os esporozoítos de Plasmodium possam utilizar um 
mecanismo conservado que lhes permita reconhecer moléculas expressas à 
superfície das glândulas salivares do mosquito e das células hepáticas do 
hospedeiro mamífero. 
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abstract 
 
Malaria is a devastating disease caused by Plasmodium parasites and 
transmitted to mammals through the bite of an infected anopheline female 
mosquito. The asymptomatic pre-erythrocytic phase of the parasite life cycle 
comprises the journey of sporozoites from the skin to the liver, their asexual 
multiplication in hepatocytes and the release of merozoites, the red blood cells 
infective forms. A crucial event for successful liver infection comprises the 
arrest of sporozoites in the sinusoids. The thrombospondin-related adhesion 
protein (TRAP) is a promising candidate to mediate this event, since trap 
knockout sporozoites cannot home to the liver. However, TRAP contains 
several adhesion domains in its extracellular portion and is also connected to 
the sporozoite actin-myosin motor through its C- terminal cytoplasmic domain. 
Thus, to further explore the role of TRAP in mediating the homing of 
sporozoites to the liver, we have successfully engineered bioluminescent 
parasites to express TRAP without the cytoplasmic tail. Indeed, the deletion of 
this domain renders sporozoites immotile but do not alter the surface 
presentation of the protein. As these sporozoites cannot invade the mosquito 
salivary glands and attain complete maturation, we have generated maebl 
knockouts as a control, a mutant line that based on previous findings remains 
in the mosquito hemolymph but do infect the liver as wild type parasites. 
Unexpectedly, we found that maebl knockout sporozoites have an impaired 
capacity to target and infect the liver of mice. Indeed, in vitro experiments 
demonstrate defective hepatocytes traversal and invasion by the maebl 
knockout sporozoites. These findings suggest that Plasmodium sporozoites 
may use a conserved mechanism for the recognition of molecules expressed 
by the mosquito salivary glands and the liver in the mammalian host. 
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Section I – Malaria, vectors and parasites 
1. Key facts about malaria 
Despite the scientific community awareness of malaria being more than a century old, this 
devastating parasitic disease still affects millions of people every year. At this moment, malaria is 
endemic in 95 countries placing 3.2 billion people at risk (World Health Organization, 2015a). The 
latest global evaluation reported in 2015, 214 million cases of paludism leading to 438 thousand 
deaths (World Health Organization, 2015a) (Fig.1). The malaria burden is higher in Africa since 90% of 
the global deaths occurred in that continent. The most vulnerable group of people are children under 
five year old, pregnant women, and non-immunized migrants (Desai et al., 2007; Jensenius et al., 
2013; World Health Organization, 2015a). Young children are particularly susceptible to develop 
severe forms of malaria, entering as the fourth highest cause of infant mortality in WHO Africa Region 
(World Health Organization, 2015a). 
Figure 1- Countries with ongoing malaria transmission. Adapted from World Health Organization, 2014. 
2. Vectors 
The transmission of parasites responsible for malaria is restricted to female mosquitoes from the 
genus Anopheles. Not all anopheline mosquitoes can act as human malaria vectors. From all the 450 
species of the genus Anopheles, only 60 are capable of transmitting the parasite to humans, although 
at different levels of concern to public health (Sylvie et al., 2008). Despite living in sympatry, the 
endemicity of a region is maintained by a single Anopheles specie, called dominant vector (Sinka et 
al., 2012).  
Besides being outnumbered, dominant species have higher vectorial capacity, which is governed 
by intrinsic (genetic factors) and extrinsic factors. With the recent sequencing of the genome of 
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several anopheline mosquitoes, including some major malaria vectors such as Anopheles gambiae, it 
was possible to understand some of the genetic determinants of mosquito competence (Holt et al., 
2002). In particular, many biological traits of mosquitoes, concerning their morphology, physiology 
and behaviour, influence their vectorial capacity. Some examples of those traits are reproduction, 
host identification and preference, blood-feeding behaviours, resistance to insecticides and immunity 
(Neafsey et al., 2015). Concerning the non-genetic influences on the vectorial capacity of mosquitoes, 
it is possible to highlight the climatic factors, diet, gut microbiota, infection history, maternal effects 
and immune priming (Lefèvre et al., 2013). Among them, climatic factors (and especially 
temperature) are particularly important because not only have an impact in vector competence by 
influencing the mosquito development and parasite viability, but also dictate the geographical 
distribution of dominant vectors and consequently, parasites biodiversity (KiszewskI et al., 2004; 
Autino et al., 2012).  
3. Parasites 
a. Plasmodium phylogeny  
Plasmodium are obligate intracellular parasites that belong to the phylum Apicomplexa, a large 
phylogenetic group of unicellular protozoans. Besides Plasmodium, this phylum includes other genera 
of parasites with marked impact on public health affecting cattle or humans, such as Babesia (Brayton 
et al., 2007), Toxoplasma (Montoya & Liesenfeld 2004), Theileria (Gardner et al., 2005; Pain et al., 
2005) and Cryptosporidium (Abrahamsen et al., 2004) (Fig.2).  
Figure 2- Phylogenetic context of the genus Plasmodium. Adapted from Aravind et al., 2003. 
There are more than 200 species of Plasmodium, capable to infect mammals, reptiles and birds 
(Ramasamy, 2014). Among them, only five can cause human malaria, namely Plasmodium vivax, 
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Plasmodium ovale, Plasmodium malariae, Plasmodium knowlesi and Plasmodium falciparum, being 
the latest the deadliest one (Oddoux et al., 2011; World Health Organization, 2015a). The rodent 
malaria species Plasmodium berghei and Plasmodium yoelii, are also important since they are used as 
model of choice in in vivo experimental malaria research (Ménard et al., 2013).  
b. Plasmodium spp. life cycle 
Despite requiring different hosts, the life cycle of mammalian Plasmodium species is very similar 
(Fig.3).  Indeed, it can be divided into three main phases: the pre-erythrocytic (PE) phase, where there 
is an asymptomatic asexual multiplication of the parasite in the liver of the vertebrate host; the 
erythrocytic phase during which parasite asexual multiplication inside red blood cells leads to the 
symptoms and complications of malaria; and the mosquito phase characterized by sexual and asexual 
multiplications of the parasites turning the invertebrate host into a potential transmission vector. In 
brief, while having a blood meal, an infected female mosquito injects sporozoites in the skin of the 
mammalian host, which travel to the liver and invade hepatocytes. Inside them, parasites transform 
into spherical exoerythrocytic forms (EEFs), which subsequently undergo several rounds of nuclear 
division to generate thousands of red blood cells (RBCs) infective forms, called merozoites. Once 
mature, merozoites are released into the bloodstream inside merosomes. This pre-erythrocytic phase 
lasts about 2 and 7-10 days in rodents and humans, respectively (Kaiser et al., 2003; Ménard et al., 
2013; Ferguson et al., 2014). However, some parasite species can form hypnozoites, a latent form 
that remains dormant in the liver for weeks to years, until they reactivate and generate blood 
infective forms, termed relapse (Chamchod & Beier 2013). Inside erythrocytes, merozoites multiply 
again, developing through ring, throphozoite and schizont stages (Cowman & Crabb 2006). Each 
merozoite can generate up to 30 new infective merozoites, which are released into the bloodstream. 
This cyclic process is responsible for clinical manifestations of the disease and lasts nearly 24 and 48-
72 hours in rodents and humans, respectively (Cowman & Crabb, 2006; Ménard et al., 2013). 
However, a small proportion of parasites transforms into sexual stages termed gametocytes, which 
are ingested by a mosquito during a blood meal. In the mosquito midgut lumen, the female and male 
gametocytes egress from red blood cells into non-motile macro and highly motile flagella-like 
microgametes, respectively (Matuschewski, 2006). The sexual reproduction occurs giving rise to a 
motile zygote, called ookinete that invades the epithelial layer of the mosquito midgut to reach the 
basal lamina and where it starts to transform into an oocyst. The oocyst undergoes several mitotic 
divisions, forming sporoblasts containing thousands of sporozoites. After 10 to 14 days of maturation, 
sporozoites egress from the sporoblast and enter in the mosquito circulatory system, the hemolymph 
(Siden-Kiamos & Louis 2004; Matuschewski, 2006). In the last step of their journey in the vector, 
sporozoites invade the salivary glands, completing their maturation and being ready for transmission 
into a new mammalian host (Ménard et al., 2013; Ferguson et al., 2014).  
Chapter I Introduction 
 
6 
 
Figure 3- The life cycle of mammalian Plasmodium species.  Plasmodium sporozoites are inoculated in the skin of the 
mammalian host through the bite of an infected anopheline female mosquito. Once in the skin, sporozoites enter the 
bloodstream and rapidly target the liver invading hepatocytes. Inside these cells, they undergo schizogony and generate 
thousands of merozoites, which are released into the bloodstream inside merosomes. Merozoites initiate repetitive cycles 
of asexual replication inside red blood cells. These cycles are responsible for malaria symptoms and complications. 
Meanwhile, some parasites transform into gametocytes, which are ingested by a mosquito during a blood meal. Inside the 
mosquito, parasites initially suffer sexual replication and then undergo sporogony, which results in the release of thousands 
of sporozoites into the mosquito hemocoel. Finally, sporozoites target the mosquito salivary glands and invade those 
structures. Infectious sporozoites can be transmitted to a new host during a mosquito blood meal, completing the cycle. 
Adapted from Ménard et al., 2013.  
4. Disease control 
By applying strategies such as vector control, chemoprevention and case management, it was 
possible between 2000 and 2015 to decrease the global malaria incidence and mortality rates among 
children under five years of age by 37% and 65%, respectively. The most astonishing 
accomplishments were related to the decrease of malaria burden in Africa, since it was possible to 
reduce the incidence of the disease by 42% and the mortality rates in young children by 71% over the 
past fifteen years (World Health Organization, 2015a). 
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a. Vector control 
Vector control has been particularly useful to reduce the malaria morbidity and mortality (World 
Health Organization, 2015a). The two core measures of this strategy were long-lasting insecticidal 
nets (LLINs) and indoor residual spraying (IRS). Whereas IRS relies only in the susceptibility of vector 
to insecticides, LLINs have the advantage of providing a physical barrier between mosquitoes and 
humans (World Health Organization 2016a). These measures can be supplemented with larval source 
control to reduce malaria vectors population, by modifying the natural habitat of mosquitoes, 
treating the mosquitoes breeding areas with larvicidal compounds and applying biological control 
measures (World Health Organization, 2015a).  
b. Chemotherapy 
Another effective strategy used in malaria control is the chemoprotection of pregnant woman and 
young children. The three main treatment strategies widely used in the field are: intermittent 
preventive treatment in pregnancy (IPTp), seasonal malaria chemoprevention (SMC) and intermittent 
preventive treatment in infants (IPTi).  All these measures cannot be effective without a proper case 
management in the field, which involves the rapid detection, diagnose and treatment of ill people. 
Malaria diagnosis can be divided in two main categories: suspected malaria and parasitological 
diagnosis. The diagnosis by suspected malaria is based on the observation and recognition of 
symptoms characteristics of malaria, such as fever. Since malaria symptoms are non-specific, this 
method is highly unreliable and usually leads to overtreatment. Thus, it is always necessary to confirm 
the suspected malaria using other methods that rely on the direct or indirect detection of malaria 
parasites, such for example by microscopic analysis of Giemsa or Fields’s blood smears or using rapid 
diagnostic tests (Moody & Chiodini, 2000; World Health Organization, 2015b). The treatment of 
malaria depends on the clinic picture of the patient, which can be classified in severe or 
uncomplicated malaria (World Health Organization, 2015b). To treat uncomplicated malaria, the 
World Health Organization (WHO) recommends the use of artemisinin-based combination therapy 
(ACT), i.e. a combination of an artemisinin derivate with another long-lasting drug with a distinct 
mode of action. Additionally, patients infected with P. vivax are treated with primaquine in order to 
prevent relapses (World Health Organization, 2015b). In contrast, the treatment for severe P. 
falciparum malaria is composed by an initial parenteral (or rectal) administration of an antimalarial 
drug, such as artesunate, following oral administration of an ACT (World Health Organization, 2015b).  
c. Vaccines  
Even after decades of study, there is still no approved human vaccine for malaria. The most 
advanced vaccine at the moment it the RTS,S/AS01 that is now under phase IV pharmacovigilance 
studies and under regulatory review for paediatric use (World Health Organization, 2016b). The RTS, S 
is a subunit vaccine that is composed of 16 tandem repeats of the immunodominant epitope of the P. 
falciparum circumsporozoite protein (CSP) together with the protein’s C-terminus fused to the pre-S2 
region of the hepatitis B virus (HBV) surface antigen. The hybrid protein self-assembles into virus-like 
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particles similar to native HBV surface antigen, with exposure of the CSP epitopes. The current 
formulation includes adjuvant AS01 that is a mixture of 3-deacylated monophosphoryl lipid A (MPL) 
and the saponin QS21 in a liposome formulation. This vaccine is able to protect infants against 
uncomplicated malaria by 27% to 39% and decrease the incidence of severe malaria by 31.5% (The 
RTS,S Clinical Trials Partnership, 2014). Vaccine efficacy is strictly correlated with the anti-CSP 
antibodies titres and their decay over time is correlated with the loss of RTS,S-induced immune 
responses (White et al., 2015). Despite conferring moderate protection against severe and clinical 
malaria the vaccine fails short of the goals established for preventing disease and eradicating the 
parasite. 
d. Current challenges  
Despite the greatest advances towards malaria control and eradication, the scientific community is 
now facing some important challenges. One of the most concerning issue is the crescent reported 
cases of P. vivax malaria worldwide (World Health Organization, 2015a). P. vivax malaria may be 
particularly challenging in terms of vector control, diagnostic and treatment. P. vivax parasites can 
undergo sporogony at lower temperatures than P. falciparum, meaning that parasites can survive in 
vectors at higher latitudes. Additionally, 95% of P. vivax infections occurs outside Africa, in regions 
were primary vectors have a higher zoophilic feeding-behaviour, i.e. their prefer to feed on other 
animals rather than humans, meaning that the control of P. vivax parasites transmission is harder to 
achieve using LLINs and IRS  (KiszewskI et al., 2004; World Health Organization, 2015a). Moreover, as 
patients infected with P. vivax develop lower levels of parasitaemia compared to those infected with 
P. falciparum, the detection of P. vivax infections can be easily missed using the conventional 
methods for malaria diagnosis (Gething et al., 2012; World Health Organization, 2015a). Besides that, 
there is no effective method to detect hypnozoites, which can cause debilitating effects to patients 
during chronic relapses, such as severe anaemia (Anstey et al., 2012). These latent hepatic forms can 
only be treated with long-term primaquine, which is linked to high levels of morbidity and mortality in 
patients with severe forms of glucose-6-phosphate dehydrogenase (G6PD) deficiency (Baird, 2015; 
World Health Organization, 2015b).   
e. Resistances 
Antimalarial drug resistance on Plasmodium parasites has been a concerning issue for decades, 
since P. falciparum gained resistance to chloroquine. This drug was discovered in the 1940s and 
integrated in global malaria control and eradication programs a decade later. However, the efforts to 
eradicate malaria were severely hampered by the emerging of chloroquine-resistant parasites (Payne, 
1987). Consequently, patients with P. falciparum malaria started to be treated with sulfadoxine-
pyrimethamine, which resulted to the rapidly acquisition of resistance to this drug by parasites (Clyde 
& Shute 1957; Nair et al., 2003; Roper et al., 2003). Thus, this harsh scenario resultant from the use of 
antimalarial drugs as monotherapies led to the current use of ATC as the first-line treatment for P. 
falciparum malaria (Antony & Parija, 2016). However, despite the actual high effectiveness of the 
treatment, P. falciparum resistance to artemisinin was already reported in 5 countries of the Greater 
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Mekong Subregion (Cambodia, Lao People’s Democratic Republic, Myanmar, Thailand and Vietnam) 
(Ashley et al., 2014; World Health Organization, 2015a).  
As parasites gained resistance to antimalarial drugs, mosquitoes are also developing resistances to 
insecticides used in vector control. Indeed, there is an increase spread of resistance to pyrethroids, 
the most used class of insecticides in malaria vector control, being used in all LLINs (Hemingway, 
2014). Despite the overuse of pyrethroids, which contributed to disseminate resistances in all major 
malaria vectors, including the P. falciparum vectors such A. gambiae and Anopheles funestus, LLINs 
remain effective for now (Ranson et al., 2011; Riveron et al., 2013; World Health Organization, 
2015a).  
Section II - Biology of Plasmodium sporozoites  
As obligate intracellular parasites, apicomplexan must invade host cells at one or more steps in 
their life cycle. To do this, parasites transform into specialized extracellular stages, usually called 
“zoites” (Ménard, 2001). In the mammalian host, the Plasmodium zoites suffer drastic morphologic 
transformations during their life cycle, varying between the banana-shaped sporozoites and the 
round-shaped merozoites (Bannister et al., 2000). These alterations are extremely relevant in the 
journey of parasites inside the host, providing to zoites the capacity to invade and colonize different 
tissues (Morrissette & Sibley, 2002).  
Among the several types of Plasmodium zoites, sporozoites have a unique capacity to become 
invasive twice in their lifetime (Sultan, 1999). Similarly to other apicomplexan parasites, Plasmodium 
sporozoites are elongated and polarized cells, 5 to 15 µm long and 2 to 5 µm wide (Levine, 1973) 
(Fig.4). Sporozoites are limited by the pellicle that continuously interacts with a set of cytoskeleton 
elements, such as actin, myosin and intermediate-like proteins. Specifically, the pellicle is composed 
by the plasma membrane along with an underlying platform of one or more flattened vesicles 
(alveolar membranes), interrupted at both anterior and posterior pole of the parasite. The alveolar 
membranes along with the cytoskeleton comprise the inner membrane complex (IMC) of the 
sporozoite (Morrissette & Sibley, 2002). Another important structure is the apical complex, a set of 
specialized organelles located at their apical pole, which includes the rhoptries, the micronemes and 
the apical polar ring. The rhoptries and the micronemes are two crucial secretory organelles essential 
for motility, cell traversal, adhesion and invasion of the host cells (Morrissette & Sibley, 2002; Ishino 
et al., 2004). Moreover, the apical polar ring is one of the three microtubule-organizing centres 
(MTOCs) of sporozoites, being the other two the spindle pole plaques and centrioles bodies (Sinden 
1978; Chobotar & Scholtyseck, 1982). This highly organized structure determine the number and 
orientation of subpellicular microtubules, which in turn provide the rigidity, cell shape and apical 
polarity to sporozoites (Russell & Burns, 1984; Nichols & Chiappino, 1987; Stokkermans et al., 1996; 
Morrissette & Sibley, 2002). Sporozoites also have dense granules, likely involved in the invasion of 
host cells and an apicoplast, an essential non-photosynthetic plastid which participate in the synthesis 
of fatty acids, isoprenoids and heme (Mercier et al., 2005; Mizushima & Sahani, 2014). 
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Figure 4- The Plasmodium sporozoite. As other apicomplexan parasites, the hallmarks of sporozoites include the apical 
complex, the inner membrane complex (IMC), dense granules and the apicoplast (not represented). The apical complex 
includes the polar ring and two secretory organelles, the micronemes and rhoptries. Whereas the rhoptries are teardrop-
shaped organelles, whose ducts opens to the apical end of the parasite, micronemes are small and round structures 
dispersed in the cytoplasm of sporozoites (Jayabalasingham et al., 2010). Another important feature is their IMC composed 
by the alveolar membranes and the parasite cytoskeleton. Dense granules are small microspheres of approximately 200 nm 
that act as secretory organelles during host cell invasion (Mercier et al., 2005).  Adapted from Frevert, 2004. 
1. Gliding motility 
Although they do not have cilia or flagella, sporozoites are highly motile. They have a substrate-
dependent type of locomotion, called gliding motility, characterized by the absence of morphological 
distortion and locomotory organelles (Heintzelman, 2015). Instead, their motility is powered by an 
actin-myosin motor anchored to the IMC and regulated by calcium-dependent mechanisms (Ménard, 
2001; Carey et al., 2014; Harding & Meissner, 2014).  
Three conditions are necessary for a successful locomotion, namely, i) the formation of transient 
contact points between the substrate and the adhesive molecules present at the parasite surface; ii) a 
molecular bridge linking the adhesins to the motor apparatus and iii) the anchorage of the motor 
internally, in order to generate mechanical force that push the parasite forward on the substrate 
(Heintzelman, 2015). Münter and colleagues in 2009 described the sporozoite gliding motility as “an 
alternating sequence of periods of run and firm adhesion”. In fact, it was demonstrated that 
sporozoite gliding relies on repetitive cycles of adhesion and posterior deadhesion to the substrate, 
generating sufficient tension to the parasite slip onwards (Münter et al., 2009). Plasmodium 
sporozoites can move at a maximum speed of 4 µm per second and their gliding pattern can vary 
between a circular and a corkscrew-like motion in a 2D and 3D matrix, respectively (Amino et al., 
2008; Kudryashev et al., 2012; Heintzelman, 2015).  
After many years of research, it was possible to understand (at least in part) how the glideosome 
works and which its molecular components are. Indeed, whereas the mechanistic components of the 
motor are conserved among Apicomplexa parasites, the adhesive molecules are specie and stage-
specific, allowing the parasite interaction with different host cells and tissues (Morahan et al., 2009). 
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At the moment three proteins linking the host receptors to the motor apparatus were described, 
namely the thrombospondin-related adhesion protein (TRAP) (Sultan et al., 1997; Kappe et al., 1999), 
TRAP-like protein (TLP) (Heiss et al., 2008) and  TRAP-related protein (TREP) (Combe et al., 2009). 
Actin and myosin A (MyoA) molecules are the core components of the glideosome, since myosins can 
convert the chemical energy of adenosine triphosphate (ATP) into mechanical energy and pull the 
actin filaments, propelling the parasite forwards (Boucher & Bosch, 2015; Heintzelman, 2015).  
Interestingly, a potential role of CSP in sporozoites gliding motility was proposed in late 1980s, 
after seeing that antibodies against this protein rendered parasites non-motile (Stewart et al., 1986). 
Despite not being associated with the glideosome, CSP is one of the most abundant proteins 
expressed on the sporozoite surface (Swearingen et al., 2016). In fact, it was later proposed that CSP 
may provide the substrate-binding sites required for gliding motility because once released from the 
apical end of the sporozoite, it forms adhesion patches with the substrate and is translocated along 
the surface of the sporozoite towards the posterior pole before being shed on the substrate (Stewart 
& Vanderberg, 1988, 1991; Sultan et al., 1997). 
2. Host cell traversal 
Besides gliding on a solid surface, sporozoites can also disrupt the host cells plasma membrane, 
glide through their cytosol and exit from it (Mota et al., 2001). This migratory behaviour was observed 
in several cell types, such macrophages, epithelial cells, fibroblasts, and hepatocytes, indicating that 
cell-type specificity apparently does not seem to exist (Vanderberg et al., 1990; Mota et al., 2001; 
Amino et al., 2008; Hamaoka & Ghosh, 2014). Regarding the fate of traversed cells, some can reseal 
their membrane integrity while others don't (Mota et al., 2001; Tavares et al., 2013; Formaglio et al., 
2014; Hamaoka & Ghosh, 2014). Many years of research using reverse genetics led to the 
identification of parasite molecules important for sporozoite cell traversal (CT), such as the sporozoite 
microneme proteins essential for cell traversal (SPECT) and SPECT2 (Ishino et al., 2004, 2005a), a 
surface phospholipase (PL) (Bhanot et al., 2005), TLP (Moreira et al., 2008), the gamete egress and 
sporozoite traversal (GEST) (Talman et al., 2011) and cell-traversal protein for ookinetes and 
sporozoites (CelTOS) (Kariu et al., 2006). Interestingly, it seems to exist a dichotomy among the 
proteins necessary for gliding motility and cell traversal. Whereas proteins associated with sporozoite 
gliding motility have adhesion properties, those associated with cell traversal possess membrane-lytic 
activity capable to disrupt the host cell membrane (Lacroix & Ménard, 2008). This behaviour seems to 
be important for the progression of sporozoites in different host tissues and to avoid parasite 
clearance by phagocytic cells (Amino et al., 2008; Tavares et al., 2013). However, it remains to be 
elucidated whether sporozoites CT contribute to host cell tolerance or immunity to parasite antigens 
and to the stimulation of anti-inflammatory mediators from traversed cells (Tavares et al., 2013). The 
role of CT in the pre-erythrocytic stage will be addressed in more detail on section III. Moreover, it 
was recently reported that sporozoites can migrate through host cells within a non-replicative 
vacuole, named transient vacuole (TV). Indeed, sporozoites enter the cells inside of a TV and exit from 
it using pH sensing and SPECT2-dependent mechanism (Risco-Castillo et al., 2015). 
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3. Host cell invasion 
During host cell invasion, sporozoites enter in host cells inside a parasitophorous vacuole (PV). 
Initially, a tight connection is formed between the sporozoite and the host cell, called tight junction 
(TJ) (Besteiro et al., 2011). This interaction starts at the apical pole of the sporozoite and 
subsequently moves to the posterior pole, surrounding the whole parasite as it enters the cell 
(Besteiro et al., 2011). The establishment of the TJ benefits the sporozoite in several ways; besides 
assisting the parasite entrance into the PV, the TJ is also involved in the vacuole biogenesis, i.e. 
participate in the selection of the biochemical components of the vacuole membrane (Besteiro et al., 
2011). Interestingly, sporozoites remodel the PV membrane in order to exclude components of the 
host plasma membrane, and thus avoiding degradation by the host lysosomal system (Zheng et al., 
2014; Risco-Castillo et al., 2015). After their entrance, sporozoites establish themselves in the host 
cell cytoplasm and multiply inside the PV (Ménard et al., 2013). 
Section III - The Plasmodium pre-erythrocytic phase 
1. The skin phase 
While taking a blood meal, the mosquito puncture directly a blood vessel or ingest blood from 
hematomas, which are small blood pools created during the blood feeding probing phase, i.e. when 
the mosquito probes the host skin for blood with it mouthpart stylets while injecting saliva (Clements, 
1992; Jin et al., 2007). Importantly, it is during this phase that sporozoites are transmitted to the 
mammalian host (Sidjanski & Vanderberg, 1997; Matsuoka et al., 2002; Vanderberg & Frevert, 2004; 
Medica & Sinnis, 2005; Amino et al., 2006; Yamauchi et al., 2007). However, rather than being 
injected directly in the blood vessels, sporozoites are inoculated in the avascular area of the skin (in 
dermis and epidermis), subcutaneous tissue and even in muscle (Vanderberg & Frevert, 2004;  Jin et 
al., 2007). The size of the parasite inoculum delivered to the mammalian host is very small, usually 
not exceeding some dozens of sporozoites (Amino et al., 2006). This phenomenon can be explained 
by several determinants. For example, despite the large number of sporozoites capable to colonize 
the mosquito salivary glands, just a small portion are free and yet a lower fraction are motile. Only 
this fraction, termed releasable pool, can colonize the mosquito salivary ducts and thus be 
transmitted to the new host. Additionally, it was also demonstrated that sporozoites are re-ingested 
when the mosquito starts to ingest host blood (Frischknecht et al., 2004; Kebaier & Vanderberg, 
2006).  
After being injected at a rate of 1 to 2.5 parasites per second, the majority of sporozoites exhibit 
forward gliding motility at rate of 1 to 2 µm per second, following a tortuous path (Amino et al., 2006; 
Jin et al., 2007). Then, these highly motile sporozoites face a tripartite fate (Fig.5). Based on time-
lapse microscopic analysis of P. berghei sporozoites, it was verified that in 1 hour, approximately 50% 
of them leave the bite site by invading actively blood (≈ 70%) or lymphatic vessels (≈ 30%), while the 
other part remain in the bite site (Amino et al., 2006). In the “lymphatic pathway”, sporozoites are 
drained to the proximal lymph node (LN) where the vast majority are captured by dendritic cells (DC). 
Chapter I Introduction 
 
13 
 
Despite some can transform into EEFs inside podoplanin-expressing cells those are unable to 
complete their development (Amino et al., 2006; Ménard et al., 2013). Regarding the sporozoites that 
remain in the bite site some can also develop into EEFs inside a PV in dermal and epidermal cells, as 
well as in association with hair follicles. In contrast to lymphatic EEFs, these can induce detachable 
merosome-like extensions in host cells full of infective merozoites. Surprisingly, it was observed that 
EEFs associated with hair follicles can be detected during several weeks. This maintenance of 
parasites viability is probably due to the presence of an immunosuppressed environment 
characterized by the absence of major histocompatibility complex (MHC) class I molecules in these 
immunoprivileged sites (Gueirard et al., 2010). 
Figure 5- The tripartite fate of Plasmodium sporozoites in the skin of the mammalian host. After being inoculated, 
sporozoites may cross the endothelial barrier of blood or lymphatic vessels or remain in the skin, near the bite site. Only the 
sporozoites that invade blood vessels reach the liver. Adapted from Ménard et al., 2013. 
The role of CT in the skin phase started to be depicted some years ago, when the fate of P. berghei 
spect and spect2 knockout (KO) sporozoites, which have a severe defect in cell traversal but not in 
gliding motility, was imaged in the skin of mice (Ishino et al., 2004, 2005a; Amino et al., 2008). After 
the observation that subcutaneous injected mutant sporozoites were less infectious to mice 
compared to mutant sporozoites injected intravenously, it was suggested that CT would have a role in 
the sporozoite passage through the host skin. In fact, the majority of mutant sporozoites was found 
to be immotile after being inoculated in the skin, contrasting with the highly motile wild-type (wt) 
parasites. Using advanced microscopic techniques, it was discovered that CT-defective sporozoites 
were rapidly immobilized in the host skin by leukocytes and that were highly associated with dermal 
fibroblasts. In contrast, it was not found any defect in their ability to actively cross either blood or 
lymphatic vessels. Thus, it seems that the major role of sporozoite CT is to avoid parasite clearance by 
phagocytic cells and allow the free movement of sporozoites in the dermis, avoiding non-specific 
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invasion events (e.g. invasion of fibroblasts), until sporozoite entry in the host circulatory system 
(Amino et al., 2008).  
The consequences of Plasmodium skin phase in the host immune system cannot be ignored. In 
rodent malaria models, the skin draining LN receives about 70% of the parasite antigens inoculated by 
the mosquito, i.e. antigens of dead lymphatic and skin sporozoites, and importantly, antigens of 
abortive EEFs. This antigenic drainage occurs in an important immunogenic context, in contrast to 
what occurs in the liver, where a strong immunotolerant environment prevails (Gueirard et al., 2010; 
Protzer et al., 2012). Indeed, CD8+ T-cells activated inside LN are major players in the fight against 
liver stage malaria, since they act against infected hepatocytes that present parasite antigens through 
their MHC complex (Chakravarty et al., 2007). Furthermore, it also known that the mosquito saliva is 
capable to trigger the mouse immune system per se since it causes mast cell degranulation, which 
induces the recruitment of antigen-presenting cells (APC) to the bite site. In addition, this recruitment 
is followed by the relocation of APC to the host lymph nodes, contributing to the host T and B 
lymphocyte priming (Demeure et al., 2005). This phase may also be clinically important, since hair 
follicles may constitute a small niche for Plasmodium erythrocytic infective forms that can eventually 
lead to malaria recurrences in mammals (Gueirard et al., 2010). The natural contribution of skin 
derived merozoites in the establishment of a blood-stage infection is hard to access as eliminating 
hepatic EEFs contribution is experimentally challenging (Gueirard et al., 2010). However, by using 
mutant P. berghei sporozoites unable to exit the inoculation site, it was demonstrated that skin EEFs 
can, in fact, induce blood-stage infection (Coppi et al., 2011). 
2. The liver phase 
The liver is a complex organ composed by several types of cells, such as hepatocytes, endothelial 
cells (EC), macrophages and hepatic stellate cells (SC). The hepatocytes are spatially arranged in cords 
separated by the liver sinusoids, which in turn are lined by a unique epithelium, composed by 
fenestrated EC. In addition, the sinusoids are surrounded by resident macrophages, called Kupffer 
cells (KC), which are mainly anchored to the endothelial walls and form cytoplasmic extensions 
capable to penetrate the gaps between adjacent EC. Between the liver sinusoids and hepatocytes, 
exists a perisinusoidal compartment, called space of Disse, composed by plasma and connective 
tissue (Motta, 1984; Senoo, 2004; Ishibashi et al., 2009; Krishna, 2013).  
Once inside the host bloodstream, sporozoites only take a few minutes to reach the liver, 
suggesting that a very specific recognition event takes place between parasite molecules and liver 
cells (Frevert et al., 2005). Although studied for decades, the molecular basis of this phenomenon is 
still debatable since it is mostly based on indirect and/or in vitro experiments. It has been proposed 
that CSP mediates the targeting of sporozoites to the liver. This protein has a conserved structure that 
comprises the signal peptide, a central repetitive domain and a C-terminal hydrophobic sequence 
(McCutchan et al., 1996). The CSP from different Plasmodium species share conserved domains 
flanking the repetitive region, such as the Region I, composed by the pentapeptide KLKQP at the N 
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terminus and the cell adhesive motif termed thrombospondin repeat type I  (TSR) at C terminus 
(Adams & Tucker, 2000). 
Several studies demonstrated that CSP can bind to heparan sulphate proteoglycans (HSPGs) 
present on the surface of hepatocytes (Cerami et al., 1992; Frevert et al., 1993; Sinnis et al., 1994). 
However, the protein domains responsible for this interaction are a debated issue: whereas some 
studies demonstrated that the TSR domain was mediating this interaction (Cerami et al., 1992; 
Frevert et al., 1993; Sinnis et al., 1994), others found that a charged motif in the N-terminal region of 
CSP, upstream from the Region I, was involved (Aley et al., 1986; Suarez et al., 2001; Rathore et al., 
2002). Despite being expressed by the majority of mammalian cells, the glycosaminoglycan chains 
(GAGs) of HSPGs structure are amenable to chemical alterations that lead to a substantial level of 
structural heterogeneity among them. Sporozoites exploit this phenomenon and preferentially 
interact with highly sulphated GAGs, expressed mostly by SC, hepatocytes and KC (Lyon et al., 1994; 
Ying et al., 1997; Pradel et al., 2004). 
The precise underlying mechanism of CSP-HSPGs interaction started to be disclosed when it was 
observed that sporozoites stop migration and invade host cells upon contact with highly sulphated 
HSPGs. Specifically, the change in the sporozoite behaviour was concomitant with the proteolytic 
cleavage of CSP (within the Region I) by a papain family cysteine protease expressed by the parasite 
upon calcium dependent protein kinase (CDPK) 6 signalling (Coppi el al., 2005, 2007). More recently, 
the same group demonstrated that CSP has two distinct conformational states in sporozoites (Coppi 
et al., 2011). Indeed, they found that the C-terminus of the protein was exposed in oocysts 
sporozoites and masked in hemolymph or salivary glands sporozoites by the N-terminus. Moreover, 
the presence of highly sulphated HSPGs triggered the cleavage of CSP, exposing the TSR adhesive 
domain at C-terminal. In the light of these results, the model that explains sporozoites progression to 
the liver and consequently invasion of hepatocytes was proposed (Fig.6): i) during the journey of 
sporozoites from the mammalian host skin to the liver, the N-terminus of CSP is masking the adhesion 
domain TSR, conferring a migratory behaviour to sporozoites and preventing non-specific adhesion 
events; ii) upon contact with the highly sulphated HSPGs, CSP is cleaved within the Region I, exposing 
the cell-adhesive TSR domain; iii) without the N-terminal region of CSP, sporozoites are able to invade 
hepatocytes (Coppi et al., 2011). 
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Figure 6- The two conformational states of CSP during the sporozoite journey from the mosquito oocyst to the liver. 
During sporozoite development inside the oocyst, the C-terminus (red) of CSP is exposed. Once released to the hemolymph, 
the C-terminus is masked by the N-terminus (green) allowing sporozoites to acquire a migratory behaviour until reaching the 
liver. Upon contact with liver HSPGs, CSP is cleaved by a protease (yellow) in the Region I near the tandem repeats (grey), 
exposing the C-terminal region of the protein. With the adhesive TSR domain exposed, sporozoites are activated to invade 
hepatocytes. Adapted from Coppi et al., 2011.  
After their arrest in the liver, sporozoites need to cross the endothelial barrier in order to reach 
the hepatocytes. The way that sporozoites manage to overcome this barrier has been a long debated 
issue. Initially, it was thought that these crossing events occurred solely via KC traversal, a hypothesis 
known as “the gateway model” (Frevert et al., 2006). Since the first evidence that KC might act as 
portals for sporozoite passage was found in 1983 using transmission electron microscopy (TEM), 
numerous studies using cell biological, biochemical and microscopy data have been published 
supporting this hypothesis (Meis et al., 1983, 1985; Vreden et al., 1993; Pradel & Frevert, 2001; 
Pradel et al., 2002; Ishino et al., 2004, 2005a, 2005b; Frevert et al., 2005; Baer et al., 2007a). Recently, 
a new explanation for this phenomenon arose from an intravital imaging study performed by Tavares 
and colleagues in 2013. In this study, the dynamics of sporozoites in the liver sinusoids was imaged 
using fluorescent P. berghei parasites and transgenic mice capable of expressing green fluorescent 
protein (GFP) in EC. In addition, the KC of mice were immunolabeled and membrane impermeable 
dies used to visualize wounded cells. Unexpectedly, it was verified that the sporozoite crossing events 
can be classified by CT-dependent or CT-independent mechanisms. In fact, sporozoites mainly use the 
CT-machinery (≈77%) to reach the hepatocytes but contrary to the expectations, the majority of the 
events occurred via EC (≈53%) rather than KC. Concerning the CT-independent crossing events 
(≈23%), it was hypothesized that the sporozoites cross the sinusoidal walls by the paracellular 
pathway, i.e. passing between two EC or between an EC and KC, or by the transcellular pathway, i.e. 
passing through EC, by means of host cellular channels or fenestrations (Tavares et al., 2013). The 
most important conclusion drawn from this study is that CT is not essential for sporozoites to reach 
the liver parenchyma. However, and similar to what was reported in the skin, this behaviour seems to 
play a role in avoiding the parasite clearance by phagocytic cells (Amino et al., 2008). Indeed, the 
majority of CT-deficient sporozoites were trapped and killed by KC (Tavares et al,. 2013). Besides the 
dual role of CT in this phase, it may also affect the adaptive immunity of the host, since traversed cells 
are able to present antigens (Ebrahimkhani et al., 2011), allowing the host to mount an immune 
response to sporozoites. However, this scenario may be hampered due to the fact that the majority 
of traversed KC cannot reseal their plasma membrane, ending up dying (Tavares et al., 2013).  
Once outside the bloodstream, sporozoite traverse several hepatocytes before invading and 
establishing in a final one (Mota et al., 2001, 2002; Frevert et al., 2005) (Fig.7). Researchers have long 
debated the role of hepatocyte traversal by sporozoites. Initially, it was suggested that this behaviour 
benefits the sporozoites, triggering their invasion mechanisms and rendering the surrounding 
hepatocytes susceptible to invasion (Mota et al., 2002; Carrolo et al., 2003; Leirião et al., 2005). 
However, the normal infectivity of CT deficient sporozoites in KC-depleted animals unequivocally 
demonstrates that hepatocyte traversal is not mandatory to invasion (Ishino et al., 2004).  
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Besides CSP, several other proteins have also been reported to mediate sporozoite infection of 
hepatocytes. According to reverse genetic studies, P36 and P36p seems to have a key role in this 
process (Ishino et al., 2005b). Whereas in vitro studies shown that p36 and p36p KO sporozoites have 
a defect in hepatocyte invasion and EEF development, their migratory behaviour through hepatocytes 
was enhanced compared to wt parasites, suggesting that these proteins are involved in commitment 
of sporozoite host cells invasion. Moreover, these proteins may also be involved in the hepatic 
development of parasites, since EEFs formed by mutant sporozoites could not develop beyond 
nuclear division (Ishino et al., 2005b; van Dijk et al., 2005). Furthermore, a recent study reported that 
the absence of the protein P113 in salivary glands sporozoites delays pre-patency (the time between 
sporozoite inoculation and detection of blood stage parasites) when parasites are transmitted to the 
mammalian host through the bite of infected mosquitoes. The expression of this protein is 
upregulated in infectious sporozoites and it seems to be related with the transformation of 
intracellular sporozoites into early liver stages, since it was revealed that p113 KO parasites can 
adhere and infect normally hepatocytes, although producing a lower number of liver stage 
merozoites (Offeddu et al., 2014). Finally, the thrombospondin-related sporozoite protein (TRSP), a 
TSR-containing protein mainly expressed in sporozoites, was also implicated in invasion of 
hepatocytes (Kaiser et al., 2004; Labaied et al., 2007). In the absence of this protein, sporozoites 
could not properly invade hepatocytes in vitro and were less infectious to mice compared to wt 
parasites (Labaied et al., 2007). Another sporozoites protein required for host cell invasion is TRAP, 
which will be addressed in detail on section IV.  
Besides the liver proteoglycans, a few host molecules were identified as receptors for the 
sporozoite adhesion and/or invasion of hepatocytes (Pradel et al., 2004). It is known that the 
tetraspanin CD81 expressed on the hepatocytes surface is required for P. yoelii and P. falciparum 
infectivity (Silvie et al., 2003). Indeed, P. yoelii failed to infect CD81 deficient hepatocytes in vivo and 
in vitro, contrary to P. berghei sporozoites, suggesting that CD81-dependent infection of hepatocytes 
may rely on a species-specific mechanism (Silvie et al., 2003). Later, it was verified that CD81 act as a 
co-receptor along with the scavenger receptor BI (SR-BI), which also affects the intracellular 
development of sporozoites (Rodrigues et al., 2008; Yalaoui et al., 2008). More recently, it was 
verified that the EphA2 receptor expressed by hepatocytes interacts with the sporozoite protein P36, 
being necessary for the establishment of a functional PV by sporozoites during liver infection 
(Kaushansky et al., 2015). 
After invasion, parasite multiplies through schizogony in order to form thousands of merozoites, 
which eventually bud off into the sinusoidal lumen inside merosomes (Fig.7). After being released, 
these vesicle-like structures accumulate in the lungs, being capable of avoiding disintegration during 
their journey. As the merosomes membrane is from host origin, parasites can evade the host immune 
system, escaping from phagocytic attack by KC after being released from hepatocytes. Indeed, 
merosomes disintegrate only in the lung microvasculature, releasing 100 to 200 merozoites to the 
bloodstream and initiate the erythrocytic phase of the parasite’s life cycle (Baer et al., 2007b).  
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Figure 7- The sporozoite passage through the host liver. Once crossing the endothelial barrier of dermal capillaries, 
sporozoites enter into the bloodstream and rapidly arrest in the liver sinusoids. Sporozoites are able to cross the endothelial 
barrier using CT-dependent or independent mechanisms, reaching the liver parenchyma, in which they traverse several cells 
before invading a final one inside a PV. After schizogony, thousands of merozoites are formed and released in the host 
bloodstream inside merosomes. Adapted from Ménard et al., 2013. 
Section IV – Aims 
At the moment, malaria is still a major public health problem worldwide. The poor efficacy of the 
most advanced malaria vaccine, along with the increasing reports of P. vivax malaria cases and 
antimalarial drug and insecticide resistances, renders the identification of new Plasmodium antigens 
for the development of vaccines a priority. The asymptomatic but metabolically active pre-
erythrocytic phase of Plasmodium life cycle appears as an appealing vaccine target (Duffy et al., 
2012). This phase represents a bottleneck in the Plasmodium life cycle, characterized by the 
extremely low numbers of parasites in the mammalian host (Pimenta et al., 2015). Furthermore, P. 
falciparum and P. vivax take almost a week to complete their development inside the liver, providing 
time to the host immune system to act (Mauduit et al., 2009). Moreover, this phase is 
immunologically relevant, since sporozoites during their journey in the mammalian host traverse and 
invade cells expressing MHC class I molecules (Amino et al., 2008; Duffy et al., 2012; Tavares et al., 
2013). 
The research proposal for this thesis was based on the work developed by the group in 
collaboration with Rogerio Amino team at Pasteur Institute in Paris aiming at identifying sporozoites 
molecules involved in crucial steps of the parasite journey in the mammalian and that could, 
eventually, be targeted by vaccine approaches. The specific homing of sporozoites to the liver is one 
of the crucial events that precedes liver infection and that the lab is interested into explore. As above 
mentioned, in the current model sporozoites target the liver due to the interaction of the major 
sporozoites surface protein, CSP, with proteoglycans expressed by liver cells (Pradel et al., 2004; 
Coppi et al., 2011).  
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Unpublished data from the lab shows that KC depletion in mice by i.v. injection of clodronate 
liposomes do not affect the sporozoites capacity to target or infect the liver (data not shown). The 
team developed an assay using whole mice live imaging and P. berghei bioluminescent sporozoites to 
quantify the percentage of bioluminescent signal in the liver immediately (7 minutes) after i.v. 
injection of parasites. Based on this assay around 70% of the total bioluminescent signal is detected in 
the liver when sporozoites from salivary glands are injected (Fig.8). The specificity of this arrest is 
given by the approximately 20% bioluminescent signal in the liver when merozoites prepared from 
blood schizonts are injected (data not shown). Surprisingly, sporozoites capacity to home to the liver 
increases with the progression of its journey in the mosquito. Indeed, homing to the liver increases 
from 24.5 ± 2.2% to 45.5 ± 0.4% to 67.4 ± 7.1% for sporozoites collected 19 days after mosquito 
infection respectively from midgut (MG), hemolymph (HEMO) and salivary glands (SG) (Fig.8A). 
Similarly, for sporozoites collected at day 23, homing to the liver increased from 26.7 ± 2.7% to 52.4 ± 
3.9% to 74.0 ± 13.6% for sporozoites from MG, HEMO and SG (Fig.8A). These observations were 
unexpected since midgut sporozoites have the CSP adhesive domain exposed (Coppi et al., 2011). A 
well-known difference between the MG and SG sporozoites is the gliding motility. To investigate the 
role of the gliding motility in the arrest of sporozoites in the sinusoids, parasites pre-incubated with 
cytochalasin D were allowed to glide on a glass slide and imaged on a fluorescent microscope. The 
projection of the several images clearly shows that sporozoites treated with cytochalasin D remain 
immotile at least during 15 minutes upon drug treatment (Fig.8B). Cytochalasin D treated sporozoites 
and DMSO treated sporozoites were injected intravenously in mice and their capacity to arrest in the 
liver quantified. No significant differences were found on the capacity of cytochalasin D treated 
sporozoites compared to control, to arrest in the liver (Fig.8B). However, a significant reduction in 
liver infection at 24 hours was detected in the mice infected with cytochalasin D treated sporozoites, 
evidencing a role for the motility on hepatocytes infection (Fig.8B). In order to better understand the 
parasite molecules mediating this phenomenon, potential candidates were selected based on a 
proteomic profiling of P. falciparum sporozoites collected either from the mosquito midgut or salivary 
glands (Lasonder et al., 2008) by applying two consecutive filters: i) up-regulation in infectious 
sporozoites; ii) presence of a signal peptide, a transmembrane domain or a 
glycosylphosphatidylinositol (GPI) anchor in its structure. The TRAP molecule was among the selected 
candidates and importantly, TRAP knockout sporozoites were shown to be defective in the homing to 
the liver (Fig.8C). 
  
The work developed in this thesis aimed to disclose the molecular mechanisms underlying the role 
of TRAP in mediating the arrest of sporozoites to the liver. Previous gene-targeting studies have 
shown that this protein is crucial for sporozoite motility and infectivity (Sultan et al., 1997). This 
protein has two adhesive domains, a TSR domain and a von Willebrand factor A domain (VWA-
domain), capable to bind proteoglycans expressed in liver cells, and an acidic cytoplasmic tail 
anchored to the sporozoite glideosome by the aldolase (Pradel et al., 2002; Buscaglia et al., 2003; 
Morahan et al., 2009). Despite the data obtained using cytochalasin D-treated sporozoites suggests 
that the gliding motility is not involved in the homing, it was necessary to validate them using a 
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genetic approach, since the inhibitory effect of cytochalasin D is reversible (Schliwa, 1982). For that, 
we have engineered parasites to express TRAP without the cytoplasmic tail, since the deletion of this 
domain renders sporozoites incapable of gliding but do not alters the surface presentation of the 
protein (Kappe et al., 1999). Similar to the phenotype of trap KO sporozoites, sporozoites expressing a 
truncated TRAP do not invade the mosquito salivary glands, therefore do not attain complete 
maturation remaining in the hemolymph (Kappe et al., 1999). For that reason, maebl KO sporozoite 
were engineered as a control, since apical membrane antigen/erythrocyte binding-like (MAEBL) 
protein is required for sporozoite infection of mosquito salivary glands but dispensable for liver 
infection (Kariu et al., 2002).  
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Figure 8- Homing of Plasmodium sporozoites to the liver. A. P. berghei GFP+:LUC+ sporozoites collected from the mosquito 
midgut (MG), hemolymph (HEMO) and salivary glands (SG) at day 19 and 23 after the infectious blood meal (left) were 
intravenously injected in C57BL/6 mice previously treated with clodronate and recorded 7 min after infection. The 
percentage of bioluminescent signal in the liver versus total body was calculated and is shown (mean ± SD; n = 3). B. 
Sporozoites were incubated with 10 µM cytochalasin D (CYTO) for 10 min on ice and their gliding motility was imaged for 5 
min and projected in red. DMSO or cytochalasin D treated sporozoites were intravenously injected in C57BL/6 mice 
previously treated with clodronate liposomes (3 days before infection) and recorded 7 min after infection following injection 
of luciferin. The percentage (mean ± SD; n = 3) of bioluminescent signal in the liver versus total body signal is represented. 
The quantification of the bioluminescent signal in the liver was also done at 24 h after infection and the average radiance 
(p/sec/cm2/sr) (mean ± SD; n=3) is shown. C. GFP+:LUC+ wt sporozoites collected from mosquitos midgut (MG), hemolymph 
(HEMO) or salivary glands (SG) and GFP+:LUC+ TRAP knockout sporozoites were intravenously injected in C57BL/6 mice 
previously treated with clodronate liposomes (3 days before infection) and recorded 7 min after infection following the 
injection of luciferin. The percentage (mean ± SD; n=3) of bioluminescent signal in the liver versus total body signal is 
represented. The quantification of the bioluminescent signal in the liver was also done at 24 h after infection and the 
average radiance (p/sec/cm2/sr) (mean ± SD; n=3) is shown. Statistical analysis, an unpaired two-tailed Student’s t-test was 
used, *, p<0.05; **, p < 0.01; ***, p<0.001. Tavares et al., unpublished. 
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1. A review of the role of TRAP and MAEBL on the sporozoites journey from the 
mosquito to the mammalian host 
 
a. Thrombospondin-related adhesion protein  
TRAP belongs to a family of proteins characterized by the presence of at least two adhesive 
modules in the extracellular portion of the protein, i.e. the TSR domain and the VWA-domain (Fig.9) 
(Kappe et al., 2004). The emergence of this family within the Apicomplexa phylum occurred earlier, 
since it is possible to find TRAP-like proteins across other Apicomplexan genera, such as Toxoplasma 
gondii microneme protein 2 (TgMIC2) in Toxoplasma (Wan et al., 1997), the Eimeria tenella 
microneme protein 1 (EtMIC1) in Eimeria (Tomley et al., 2001), Neospora caninum microneme protein 
2 (NcMIC2) in Neospora (Lovett et al., 2000), Babesia bovis TRAP homologue (BbTRAP) in Babesia 
(Gaffar et al., 2004) and thrombospondin-related adhesive protein of Cryptosporidium 1 (TRAPC1) in 
Cryptosporidium (Spano et al., 1998). In Plasmodium, several members of TRAP family of proteins are 
expressed, such as the TRAP in sporozoites, the CS-and-TRAP-related protein (CTRAP) in ookinetes 
and the merozoite TRAP homologue (MTRAP) in blood-stages (Trottein et al., 1995; Baum et al., 
2006).  
The 200-amino-acid long VWA-domain is present in a superfamily of proteins that include soluble 
proteins, extracellular matrix proteins and also integral membrane proteins (Fig.9) (Morahan et al., 
2009). The crystal structure of this domain revealed that this protein unit acquires a classic α/β 
Rossman fold consisting in seven amphipathic α–helices surrounded by a β-sheet (Emsley et al., 1998; 
Li et al., 1998). This domain also encompasses a metal ion-dependent adhesion site (MIDAS), an 
important motif for divalent cation binding, receptor recognition and cell adhesion, composed by 5 
non-contiguous amino acids (Asp-X-Ser-X-Ser), which shelters a Mg2+ ion at the centre of its binding 
site (Springer, 2006; Morahan et al., 2009). In addition, structural studies of TRAP revealed that the 
WVA-domain encompasses two ligand-binding sites, namely the MIDAS motif and a basic heparin-
binding site (Akhouri et al., 2004; Pihlajamaa et al., 2013). Similar to CSP, TRAP also has the TSR 
adhesive domain (Fig.9). This domain is found on transmembrane and extracellular matrix proteins 
with important roles on matrix organization, cell guidance and direct interaction between cells 
(Morahan et al., 2009). Commonly, the TSR domain is composed by approximately 60 amino acids 
and shelters a central motif encompassing Trp-Ser-X-Trp followed by Cys-Ser-X-Thr-Cys-Gly (Morahan 
et al., 2009). The ligand-binding site is located at the N terminal portion of the domain and similar to 
the CSP, TRAP TSR domain has affinity to heparan sulphate proteoglycans expressed on the surface of 
hepatocytes (Robson et al., 1995; Müller et al., 1993; Tossavainen et al., 2006). Using a surface 
plasmon resonance technology to analyse the interaction between TRAP and heparin, Akhouri and 
colleagues in 2004, demonstrated the affinity to heparin to TRAP increases when the TSR and VWA-
domain act together, which may explain the conformational changes that occur in the protein upon 
binding to the receptor and suggests that both adhesion domains may participate in the sporozoite 
adherence and invasion of host cells (Akhouri et al., 2004; Morahan et al., 2009). Indeed, this 
hypothesis was in agreement with a previous study that used genetically modified parasites 
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harbouring loss-of-function mutations in the TSR and VWA-domain of TRAP: whereas mutants 
harbouring mutation in one domain were less infective to cultured cells, mosquito salivary glands and 
rodent liver, mutants bearing mutation in both domains were non-infective (Matuschewski et al., 
2002a).  
Contrarily to the adhesion domains, the structure of TRAP cytoplasmic tail (Fig.9) is not similar 
among the members of this family of proteins, being the only resemblance among them the presence 
of a conserved tryptophan residue at the C-terminal region, the YXXφ motif (where φ is any 
hydrophobic residue) and the abundance of acidic amino acids (Robson et al., 1988; Morahan et al., 
2009). The cytoplasmic tail is required for TRAP sorting, since the tyrosine-based motif is responsible 
for a proper targeting of the protein to micronemes and sporozoite surface (Bhanot et al., 2003).  
Figure 9- Domain architecture of the thrombospondin-related adhesion protein (TRAP). The extracellular portion of TRAP 
is composed of a signal peptide (SP), two adhesion domains, namely a von Willebrand factor A domain (VWA-domain) and a 
thrombospondin type-I domain (TSR), and portion of tandem amino acid repeats (Tandem repeats). The protein has also a 
transmembrane domain (TD), along with an acidic cytoplasmic tail (CTD) (Adapted from Kappe et al., 2004). 
TRAP was originally detected in Plasmodium blood stages but was found to be predominantly 
expressed by infectious sporozoites (Robson et al., 1988, 1995; Rogers et al., 1992).  This protein is 
rapidly secreted to the sporozoites surface upon contact with host cells (Gantt et al., 2000). 
Immunofluorescence analysis showed that the protein usually appears as a faint patchy pattern at the 
surface of sporozoites, although sometimes forms a “cap” over a pole of the parasites or one or two 
rings surrounding their surface (Kappe et al., 1999; Gantt et al., 2000).  
The role of TRAP in gliding motility started to be depicted when Sultan and colleagues in 1997 
reported that trap KO sporozoites were not capable of gliding, invading mosquito salivary glands or 
infecting the rodent liver. Later on, it was shown that sporozoites engineered to express TRAP 
without the 14 or 37 carboxyl-terminal residues of its cytoplasmic tail domain present a similar 
defective phenotype of trap KO (Kappe et al., 1999). Indeed, while the function of TRAP was severely 
impaired upon changes on its intracellular domain, the surface presentation of the protein remained 
unchanged (Kappe et al., 1999). In addition, mutants phenotype whose TRAP cytoplasmic tail was 
substituted by that of TgMIC2 did not differ from wt sporozoites in terms of infectivity and gliding, 
therefore suggesting that the molecular mechanism underlying sporozoites gliding and invasion is 
conserved among the Apicomplexa (Kappe et al., 1999). The role of TRAP in sporozoite gliding motility 
was further explored by Münter and colleagues, 2009. In this study, the authors verified that in the 
absence of TRAP, sporozoites could still form adhesion sites but were unable to brake them, resulting 
in a defective gliding pattern to which the authors named “patch gliding”, similar to the gliding 
pattern described by Kappe and colleagues in 1999, for sporozoites harbouring mutations in the 
cytoplasmic tail domain of TRAP. This suggests that, although being dispensable for the formation of 
the initial adhesion sites, TRAP is essential for sporozoite gliding motility, coordinating the turnover of 
contact sites and thus ensuring a unidirectional gliding pattern (Münter et al., 2009).  
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The ectodomain of TRAP needs to be shed for sporozoites to glide and invade a host cell. Indeed, a 
few years ago it was verified that TRAP can be cleaved by the rhomboid protease (ROM) 4, an enzyme 
highly expressed in sporozoites with a substrate transmembrane domain for cleavage (Le Roch et al., 
2003; Baker et al., 2006). Later, this issue was further investigated using two mutant parasite lines 
harbouring targeted mutations in two canonical rhomboid motifs present in the transmembrane 
domain of TRAP, specifically the motif AGGIIGG and FFFIIGG (Ejigiri et al., 2012). Interestingly, these 
mutations led to an accumulation of TRAP at the surface of sporozoites, suggesting that these motifs 
are critical for the shedding of the molecule. Moreover, these mutants displayed an impaired 
infectivity to mosquito salivary glands and were 10 to 100 less infectious to mice when compared to 
wt sporozoites. The defective phenotype of the mutant sporozoites was concomitant with a defect in 
gliding motility and also in cell traversal. Moreover, mutants incapable of shedding TRAP accumulate 
the protein all over their surface, suggesting that TRAP might be shedded in a stochastic manner, 
contributing for the smooth gliding pattern observed in wt sporozoites (Ejigiri et al., 2012).  
Finally, the whole picture was completed when it was discovered the mode of interaction of TRAP 
with the glideosome. Indeed, the cytoplasmic tail is anchored to the fructose-1, 6-bisphosphate 
aldolase, which in turn is associated to F-actin, forming a ternary complex (Kim et al., 1998; Buscaglia 
et al., 2003; Jewett & Sibley, 2003). As this enzyme is a tetramer, composed by four identical 
subunits, different subunits can bind at the same time with TRAP and actin (Bosch et al., 2007). 
Biochemical and structural studies reported that the key residues of TRAP cytoplasmic tail that seems 
to allow the binding with the aldolase are a sub-terminal tryptophan residue along with two non-
contiguous stretches of negatively charged residues. Interestingly, it was found that aldolase is 
localized at the surface of micronemes containing TRAP, possibly interacting with the cytoplasmic tail 
of TRAP, since the latest is protruding towards the cytoplasm, whereas TRAP N-terminal region is 
facing the lumen of micronemes. This early association between TRAP and aldolase may explain the 
sorting of the aldolase to the space between the IMC and the plasma membrane of sporozoites (Ngô 
et al., 2000). Thus, the actin-aldolase-TRAP ternary complex would be assembled upon sporozoite 
activation (Gantt et al., 2000; Bosch et al., 2007). 
Concerning the host side, it was reported that a 12 amino acid long-peptide, named SM1, is 
capable to bind to the surface of mosquito salivary glands, competing with the binding of TRAP 
(Ghosh et al., 2009). This peptide is a mimitope of TRAP VWA-domain and it was verified that can 
efficiently bind to saglin, a glycosylated homodimer of 50kDa present on the surface of mosquito 
salivary glands (Okulate et al., 2007). Indeed, the specificity of this interaction was confirmed upon 
observation that a recombinant TRAP VWA-domain peptide harbouring a specific mutation in the 
MIDAS motif was not able to bind saglin. Additionally, upon injection of α-saglin antibodies into 
infected mosquitoes, P. falciparum sporozoites displayed an impaired infection of salivary glands. 
Since these observations may occur due to a steric effect of the bulk antibody, saglin expression was 
knockdown using interference RNA in the mosquitoes. Interestingly, P. falciparum sporozoites barely 
infect the salivary glands of mosquitoes injected with saglin dsRNA, suggesting that this receptor 
interacts with TRAP during sporozoite infection of salivary glands (Ghosh et al., 2009).  
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Due to the importance of TRAP in the pre-erythrocytic stage of Plasmodium life cycle, a number of 
studies tried to report inhibitory effects on sporozoite motility and/or invasion using antibodies 
against distinct portions of TRAP. However, the results were highly variable, since some studies 
reported strong inhibition (Rogers et al., 1992; Spaccapelo et al., 1997), whereas others reported 
moderate inhibition (Charoenvit et al., 1997), or even no activity (Gantt et al., 2000). Despite these 
contradicting results, a multivalent subunit malaria vaccine using TRAP as a component is being 
developed (Moorthy et al., 2004; Rampling et al., 2016). However, it is importantly to highlight that 
the TRAP epitopes may be altered since it was recently demonstrated that TRAP suffers post-
translational modifications, being glycosylated (Swearingen et al., 2016).  
b. Apical membrane antigen/erythrocyte binding-like protein 
MAEBL is a transmembrane protein initially described in the rodent species P. berghei and P. yoelii 
but was found later to be expressed across Plasmodium genus (Kappe et al., 1998; Martinez et al., 
2013). MAEBL was original reported to be involved in host cell invasion by merozoites but was later 
described to be constitutively expressed in multiple developmental stages of Plasmodium life cycle, 
including sporozoites and late liver stages (Kappe et al., 1998, 2001; Ghai et al., 2002; Kariu et al., 
2002; Preiser et al., 2004; Singh et al., 2004; Srinivasan et al., 2004). In P. berghei sporozoites, MAEBL 
was reported in micronemes (Kariu et al., 2002), whereas other studies reported a co-localization of 
MAEBL with the rhoptries of P. yoelii and P. falciparum merozoites (Kappe et al., 1998; Noe & Adams, 
1998; Blair et al., 2002; Ghai et al., 2002). 
The C-terminal portion of MAEBL, which includes a sequence of amino acid tandem repeats and a 
cysteine-rich region (C-cys) (Fig.10), was found to be structurally related with Plasmodium Duffy-
binding like (DBL) proteins, a family of micronemal proteins produced by merozoites involved in the 
adhesion and formation of the TJ during erythrocyte invasion (Miller et al., 1979; Adams et al., 1992, 
2001). This family also includes several relevant parasite antigens, such the erythrocyte binding 
antigen 175 (EBA-175) of P. falciparum (Sim et al., 1990; Tolia et al., 2005) and the Duffy antigen 
binding proteins of P. knowlesi and P. vivax (Adams et al., 1990). Later, MAEBL was included in the 
expanded erythrocyte binding-like (EBL) family of proteins, composed not only by DBL proteins, but 
also by putative P. falciparum erythrocyte binding proteins such as the erythrocyte-binding ligand-1 
(EBL-1), EBA-140 (BAEBL), EBA-165 (PEBL) and EBA-181 (JESEBL) (Adams et al., 2001; Li et al., 2012). 
However, MAEBL stands out from this group of proteins, since it contains two cysteine-rich adhesion 
domains homologous to the apical membrane antigen 1 (AMA-1) in its N-terminal portion, named M1 
and M2, capable of binding to red blood cells in vitro (Fig.10) (Kappe et al., 1998). Despite the protein 
being expressed in blood-stage parasites, the absence of MAEBL does not affect their development 
(Kariu et al., 2002).  
This chimeric protein shares other features with EBL proteins, such for example, being encoded by 
a gene with multi-exon structures and conserved exon/intron boundaries (Kappe et al., 1998; Adams 
et al., 2001). In Plasmodium, exon boundaries are delimited by consensus donor and acceptor splicing 
junctions, similar to most eukaryotes. Indeed, maebl is one of the few described Plasmodium genes 
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that suffer post-transcriptional alternative splicing (Singh et al., 2004). This was not surprising, since it 
may act as a mechanism to allow the parasite to use the same ligand to interact with different host 
receptors over their complex life cycle (Singh et al., 2004). Indeed, maebl 3’ exons are alternatively 
spliced generating mainly two distinct MAEBL coding sequences (CDS): a CDS for an insoluble isoform 
(ORF1) containing C-terminal transmembrane domain and a CDS for a soluble isoform (ORF2) without 
the C-terminal domain. Despite these two isoforms splicing pattern occurred in sporozoites, full-
length MAEBL appears to correlate better with the ORF1 transmembrane transcript (Singh et al., 
2004). In addition, it was demonstrated that instead of being tissue-specific, the expression of MAEBL 
is regulated within the developmental cycle of sporozoites: in midgut sporozoites, MAEBL is 
expressed as a full-length protein; after sporozoite egressing from oocyst, MAEBL undergo a post-
translational processing, to be de novo expressed in infectious sporozoites upon invasion of mosquito 
salivary glands  (Preiser et al., 2004; Singh et al., 2004). 
Figure 10- Domain architecture of the apical membrane antigen/erythrocyte binding-like protein (MAEBL). MAEBL is a 
chimeric protein whose extracellular portion includes a signal peptide (SP), two adhesion domains homologous to AMA-1, 
namely M1 and M2, amino acid tandem repeats (Tandem repeats) and a cysteine-rich region (C-cys). Additionally, MAEBL 
has also a transmembrane domain (TD) and a cytoplasmic tail (CTD) (Adapted from Kappe et al., 2004).  
The role of MAEBL in sporozoite infection started to be depicted when Kariu and colleagues, 2002 
engineering maebl KO sporozoites and verified that the protein is essential in sporozoite infection of 
the mosquito salivary glands. Specifically, the defect seems to involve the adherence of sporozoites to 
those structures. However, the lack of infectivity of maebl KO sporozoites to the mosquito salivary 
glands was not concomitant with a defective gliding motility contrasting with Plasmodium TRAP 
mutant lines created in previous gene-targeting studies (Sultan et al., 1997; Kappe et al., 1999). 
Moreover, it was later verified that MAEBL isoform ORF1 is essential for P. falciparum to infect the 
mosquito salivary glands, suggesting that the role of MAEBL in mediating this step of Plasmodium life 
cycle is conserved in different parasite species (Saenz et al., 2008). It was also demonstrated that 
MAEBL does not have any role in sporozoite infection of the mammalian host, since maebl KO 
sporozoites could infect rat liver at the same extent as wt sporozoites (Kariu et al., 2002).  
As abovementioned, MAEBL is expressed (de novo) in infectious sporozoites, which may indicate a 
role in sporozoite infectivity to the mammalian host (Preiser et al., 2004; Singh et al., 2004). Despite 
the study performed by the Kariu group in 2002 indicating that expression of MAEBL is not required 
for the establishment of a successful liver infection by sporozoites, studies using antibodies against 
distinct portions of MAEBL have been reporting the opposite. Indeed, it was demonstrated that 
antibodies against the M1, M2 and C-cys domains of P. yoelii MAEBL were capable to partially inhibit  
sporozoites infection of mouse hepatocytes (Preiser et al., 2004). Specifically, the higher inhibition 
was obtained when antiserum to the M1-domain was used, being capable of reducing the number of 
EEFs by approximately 40%. This inhibitory effect was also observed using antibodies against the M2-
domain of the canonical form or against the C-terminal of the alternative form of P. falciparum 
MAEBL (Peng et al., 2016). Moreover, it was recently proven that MAEBL is highly immunogenic pre-
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erythrocytic antigen, since sera of immunized human volunteers under chloroquine cover could 
recognize at a great extent the protein (Peng et al., 2016).
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Section I – Maintaining the life cycle of P. berghei parasites in laboratory 
The general procedures concerning the maintenance of the P. berghei–mosquitoes-rodent system 
of experimental malaria are explained in this section and were divided into two subsections: 
maintaining parasites in the vertebrate and invertebrate hosts. 
1. Maintaining P. berghei in the vertebrate host 
NMRI or C57BL6 male or female mice were purchased from Charles River Laboratories and were 
housed at the Institute for Research and Innovation in Health (I3S) animal facility under a 12 hours 
alternating cycle of light-dark and access to food and water ad libitum. All the experiments were 
performed in accordance with the Institute for Research and Innovation in Health Animal Ethics 
Committee and the Portuguese National Authorities for Animal Health guidelines, according to the 
statements on the directive 2010/63/EU of the European Parliament and Council.  
Blood-stage parasites were produced in mice, according to methods described previously 
(Ramakrishnan et al., 2013). In brief, mice were infected either with blood-stage parasites or 
sporozoites, depending on the purpose of the experiment. Specifically, in case of infection with 
blood-stage parasites, mice became infected upon i.v.  injection of heparinized blood from an 
infected animal or intraperitoneal (i.p.) injection of cryopreserved parasites. Alternatively, mice were 
infected intravenously with sporozoites in PBS.  
To monitor the infection of mice, their parasitaemia was assessed by analysis of Giemsa-stained 
thin blood smears (Ramakrishnan et al., 2013). The parasitaemia was calculated by dividing the 
number of infected RBCs by the total number of RBCs in the field; the average parasitaemia of 10 to 
30 fields of approximately 500 RBCs per field was routinely counted. When the parasitaemia of mice 
was above 1%, animals were euthanized by cervical dislocation under deeply inhaled anaesthesia. For 
some experimental procedures, such as storage of parasites and extraction of parasite genomic DNA 
(gDNA), isoflurane-anesthetized animals were exsanguinated via cardiac puncture using a heparinized 
syringe. For the preparation of parasite stocks, the collected blood was diluted in Alsever's solution 
containing 10% glycerol at a ratio of 1:2 and aliquoted into several 1 ml cryogenic vials. Aliquots were 
frozen at -80°C and then transferred to a liquid nitrogen storage container (Sinden et al., 2002). 
2. Maintaining P. berghei in the invertebrate host 
Anopheles stephensi mosquitoes (SDA 500 strain) were reared at the Centre for the Production 
and Infection of Anopheles at the Pasteur Institute, Paris, France, and then infected and maintained at 
the I3S, Porto, Portugal. An acclimatized room at 20°C was used as insectary, in which mosquitoes 
were caged in autoclavable metal-frame cages and kept inside humidified incubators at 20.5 ± 0.5°C. 
Moreover, they were maintained in a regular 12 hours light-dark cycle and were fed with 10% sucrose 
solution-soaked cotton pads placed on the netting of cages, which were changed twice a week. Two 
to three days after their arrival, mosquitoes were allowed to have an infectious blood meal, using 
mice with parasitaemia and gametocytaemia (percentage of RBCs infected with gametocytes) values 
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around 5% and 0.5%, respectively. The infectious blood meal procedure is described in detail by 
Ramakrishnan and colleagues, 2013. Briefly, mice were anesthetized through i.p. injection of 
ketamine/xylazine mixture (ketamine 125 mg/kg, xylazine 12.5 mg/kg) and then were laid down on 
the netting of mosquito cages (one or two mice per cage). Female mosquitoes were fed ad libitum, 
but in order to avoid mosquitoes overeating of blood, the position of mice was changed every 5 
minutes for approximately 45 minutes. During feeding, mice were kept anaesthetized and were 
covered by large pieces of cotton minimizing their risk of hypothermia. After mosquitoes finish their 
meal, the animals were sacrificed by cervical dislocation. One week later, mosquitoes were allowed to 
feed on non-infected animals (naïve blood meal), as described above (Sinden et al., 2002). 
The dissection of mosquitoes occurred 19 to 21 days after their infectious blood meal, using a 
fluorescent stereoscope, and was performed as described previously (Carey et al., 2013; 
Ramakrishnan et al., 2013; Sato et al., 2014). Briefly, after being collected from their cages using an 
electric insect vacuum, mosquitoes were transferred to a tube and placed on ice. Once anesthetized, 
they were washed with 70% ethanol, and then with PBS and placed on a glass slide. To collect the 
salivary glands, the thorax of mosquitoes was gently pressed towards the slide while their heads were 
pulled away with the help of two needled syringes, releasing the salivary glands that appear as a pair 
of three-lobed structures. The salivary glands were gently collected to and ice-cooled tube with PBS. 
To collect the hemolymph, the distal abdominal segment of mosquitoes was removed and their 
thorax was gently washed via injection of 30 µl of PBS into a pinhole located underneath their wing. 
The drained fluid was immediately collected and placed on an ice-cooled tube. Then, while grasping 
the thorax of mosquitoes with a needle, their penultimate abdominal segment was slowly removed 
using the other needle, exposing the midgut of mosquitoes. Midguts were gently cleaned by 
removing the Malpighian tubules if necessary, and were collected to an ice-cooled tube with PBS. The 
prevalence of P. berghei infection in mosquitoes was calculated by dividing the number of midgut GFP 
positive mosquitoes by the total number of dissected mosquitoes. To count sporozoites, midgut and 
salivary glands were mechanically disrupted using a sterile micropestle. Sporozoites were then diluted 
and counted in a plastic slide with a counting grid, under a light microscope.  
Section II – Molecular biology 
1. Preparation of blood and extraction of parasite genomic DNA  
The preparation of infected blood for extraction of parasite gDNA was performed based on the 
protocol described by Ménard and Janse, 1997. In brief, blood of infected mice was collected by 
cardiac puncture and diluted by adding PBS to a final volume of 5 ml. The blood was allowed to pass 
through a Plasmodipur filter (Eurodiagnostica), previously rinsed with PBS, in order to remove 
leukocytes. Then, the filters were washed with PBS and the filtrate added to the filtered blood. To 
lysate RBCs, saponin was added to the suspension to a final concentration of 0.15% (v/v) and 
following an incubation period of 5 minutes at room temperature (RT), parasites were collected by 
centrifugation at 3200g for 20 minutes. The supernatant was discarded and the pellet washed twice 
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by resuspending in 2 ml of PBS and centrifugation at 12000g for 5 minutes. If not processed 
immediately, the parasites pellet was stored at -20°C.  
The extraction of parasite gDNA was performed using the QIAamp DNA Blood Mini kit (Qiagen), 
following the manufacturer instructions. Quantification of the extracted gDNA was performed by 
using a spectrophotometer. 
2. Construction of transfection vectors  
For the construction of all vectors, the amplification of the homology regions was accomplished by 
PCR using P. berghei ANKA strain clone 676cl1 expressing a GFP-Luciferase genomic DNA (P. berghei 
ANKA GFP+:LUC+ ; Franke-Fayard et al., 2008). Primer sequences are represented in Table I. 
a. Targeting maebl in P. berghei parasites 
Two DNA fragments corresponding to maebl (PBANKA_0901300.2) 5’ and 3’ untranslated regions 
(UTRs) were amplified using a high-fidelity Taq DNA polymerase with proofreading activity (Takara) 
and the primer pairs P1/P2 and P3/P4, respectively. The PCR conditions were as follows: initial 
denaturation step (2 minutes at 98°C), 35 cycles of denaturation (10 seconds at 98°C), annealing (30 
seconds at 55°C) and elongation (40 seconds at 68°C) and a final elongation step (5 minutes at 68°C). 
PCR products were isolated from a 1% agarose gel after electrophoresis, using the kit NucleoSpin® Gel 
and PCR Clean-up (Macherey-Nagel). These fragments were cloned into a pGEM-T Easy vector 
(Promega), sent for sequencing and checked against P. berghei genome database (PlasmoDB, 
http://plasmodb.org/plasmo/) using the Basic Local Alignment Search Tool (BLAST). The resulting 
vectors were double digested with KpnI and ClaI or EcoRI and BamHI, allowing the insertion of the 
UTRs into either side of the selectable marker cassette (T. gondii dhfr/ts ORF flanked by the upstream 
and downstream control elements of P. berghei dhfr/ts) of a transfection vector pL0001 (MRA-770; 
MR4), yielding plasmid pMAEBL.  
b. Targeting trap in P. berghei parasites 
The regions corresponding to trap (PBANKA_1349800) 5’ and 3’ UTRs were amplified using a high-
fidelity Taq DNA polymerase with proofreading activity (Takara) and the primer pairs P11/P12 and 
P15/P16, respectively. Importantly, the promoter region of trap was not comprised in the fragment 
corresponding to 5’UTR. The PCR conditions were as follows: initial denaturation (2 minutes at 98°C), 
35 cycles of denaturation (10 seconds at 98°C), annealing (30 seconds at 55°C or 50°C, concerning the 
primer pairs P11/P12 or P15/P16, respectively) and elongation (40 seconds at 68°C) and a final 
elongation step (5 minutes at 68°C). PCR products were isolated from a 1% agarose gel after 
electrophoresis, cloned into a pGEM-T Easy vector (Promega), sequenced and checked against 
PlasmoDB. The promoter and open reading frame (ORF) of trap, henceforth called pORF, were 
amplified using the primer pair P13/P14 and the following PCR conditions: initial denaturation (2 
minutes at 98°C), 35 cycles of denaturation (10 seconds at 98°C), annealing (30 seconds at 55°C) and 
elongation (40 seconds at 68°C) and a final elongation step (5 minutes at 68°C). The PCR product was 
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isolated from a 1% agarose gel after electrophoresis, cloned into a pCR-XL-TOPO® (Invitrogen), 
sequenced and checked against PlasmoDB. The resulting vector was digested with SalI and BamHI, 
allowing the fusion of 3’UTR with the 3’end of the pORF (pORF_3’UTR). The 5’UTR and pORF_3’UTR 
were inserted into a transfection vector pL0001 (MRA-770; MR4), on each site of the selectable 
marker cassette, using the unique cloning sites KpnI/HindIII and EcoRV/BamHI, respectively, yielding 
plasmid pCTR. The plasmid pCTD- harbours a truncated version of the ORF of trap, lacking 111 
nucleotides upstream of the stop codon (Kappe et al., 1999). pCTD- was engineered exactly in the 
same manner as plasmid pCTR, but using the primer pair P13/P21 for the amplification of a DNA 
fragment corresponding to trap promoter region and truncated ORF (pORFctd-); importantly, a stop 
codon was encoded in the reverse primer P21. PCR conditions were also the same as used for the 
amplification of pORF, with the exception that primers annealed at 53°C.  
The targeting constructs were prepared to be used in the transfection of parasites accordingly 
Ménard and Janse, 1997. In brief, Escherichia coli DH5a containing the vectors p∆MAEBL, pCTR or 
pCTD- were inoculated in Luria Broth (LB) with ampicillin (100 µg/ml), and cultured overnight at 37 °C 
and 200 rpm agitation. Transfection vectors were isolated from bacteria and digested with KpnI and 
BamHI, yielding maebl, trap and trapctd- linearized targeting constructs. The constructs were isolated 
from a 1% agarose gel after electrophoresis, semi-quantified and stored at -20°C. 
3. Transfection of parasites 
The practical aspects of transfecting P. berghei ANKA GFP+:LUC+ blood-stage parasites are divided 
here as follows: in vitro synchronization of schizonts; purification of schizonts; electroporation of 
schizonts and injection into mice and drug selection of transfectants. All these procedures were 
performed based on the protocols described previously (Ménard & Janse, 1997; Janse et al., 2006). 
a. In vitro synchronization of schizonts 
Mice were infected with an i.p. injection of cryopreserved P. berghei ANKA GFP+:LUC+ blood-stage 
parasites. Once parasitaemia was above 1%, a few microliters of its blood was transferred into two 
mice yielding a final parasitaemia of 0.001%. Their parasitaemia was assessed at day 3 post-infection 
and once it reached values around 5%, their blood was collected by cardiac puncture for the 
synchronization of schizonts in vitro. The collected blood was immediately transferred to a tube 
containing RPMI1640 culture medium supplemented with 20% heat inactivated fetal bovine serum 
(FBS). Infected RBCs were harvested by centrifugation at 450g for 8 minutes and resuspended in 50 
ml of RPMI1640, 20% FBS, supplemented with neomycin (50 µg/ml). The resulting suspension was 
then equally distributed among two cell culture flasks T-75 and diluted with 25mL of RPMI1640, 20% 
FBS with neomycin (50 µg/ml). The flasks were flushed with a gas mixture (5% CO2, 5% O2, 90% N2) for 
90 seconds and placed in a shaker incubator at 36.5 ± 0.5°C at a speed just enough to avoid cell 
sedimentation. Then, schizonts were allowed to synchronize overnight for a 16 hours period (Janse et 
al., 2006).  
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b. Purification of schizonts 
A small sample of blood collected from the overnight cultures was smeared over a glass slide. 
After Giemsa-staining, the slide was analysed to assess the quality of schizonts, i.e. to check if the 
majority portion (70 to 80%) of parasites appeared as viable schizonts (Janse et al., 2006). If it was not 
the case, the cultures were placed back into the incubator for 1 to 2 hours. Once fully mature, 
schizonts were separated from non-infected erythrocytes by density-gradient centrifugation. In brief, 
50 ml of 50% (v/v) Nycodenz-PBS solution were prepared, by adding equals amounts of Nycodenz 
density-gradient stock solution (138 g Nycodenz powder in 500 ml 5mM Tris:HCl, 3 mM KCl, 0.3 mM 
CaNa2EDTA, pH 7.5) and PBS. After distributing the parasite culture equally among three 50 ml Falcon 
tubes, 10 ml of 50% (v/v) Nycodenz-PBS solution was gently added to each tube under the culture 
suspension, in order to form two distinct and well-defined aqueous layers. Centrifugation occurred at 
450g for 20 minutes at RT without brake. During this step, the DNA solution (needed at later steps) 
was prepared by diluting 10 µg of maebl, trap or trapctd- linearized targeting constructs into 10 µl of 
sterile water. Meanwhile, schizonts were collected by gently aspirating the brownish grey layer at the 
interface between the two suspensions to a new tube. Up to 40 ml of fresh RPMI1640, 20% FBS 
medium was added to the collected schizonts and the suspension was centrifuged at 450g for 8 
minutes. The schizonts-containing pellet was carefully resuspended in 1 ml RPMI1640, 20% FBS 
medium and then diluted at a final concentration of 1:10 (resuspended schizonts: medium). The 
suspension was then aliquoted in a way that one single tube contains the amount of parasites 
necessary for one transfection, i.e. 0.5 to 1x107parasites (Janse et al., 2006).  
c. Electroporation of schizonts and injection into mice 
Electroporation of schizonts was performed using The Amaxa® Nucleofector® Technology (Amaxa). 
Schizonts were mixed with 100 µl Nucleofector solution 88A6 (Amaxa) containing already the DNA. 
The suspension was transferred to an electroporation cuvette, which was placed in the 
electroporation device, and merozoites were transfected using the program U33. Immediately after 
electroporation, the suspension was diluted by the addition of 50 µl of RPMI1640, 20% FBS medium 
and i.v. injected in two mice. 
d. Drug selection of transfectants 
One day after infection with transfected parasites, mice started to be treated with pyrimethamine 
(0.07mg/ml) given in drinking water (Janse et al., 2006). Their parasitaemia began to be daily assessed 
one week after infection to monitor the appearance of drug-resistant parasites. The emerging 
parasite populations in the infected animals, henceforth referred as parental population 1 and 2 (PP1 
and PP2), were allowed to multiply until infecting 1% of mice RBCs. Then, to perform another round 
of drug selection, 1x106 infected RBCs of each mouse were transferred into two mice, yielding 
transfer populations 1 to 4 (TP1, TP2, TP3 and TP4). Once parasitaemia was near 5% the blood of 
infected animals was collected by cardiac puncture for storage of parasites and genotype analysis of 
parental and transfer populations.  
Chapter II Material and Methods 
36 
 
4. Cloning of parasites 
After assessing the genotype of parental and transfer populations of parasites by PCR (see PCR 
strategies in the “Genotypic analysis of mutant parasites” subsection), a proper transfer population 
was selected for cloning. 
Cloning of parasites was performed using the limiting dilution method described by Ménard and 
Janse, 1997. Briefly, a cryopreserved stock of a transfer population was intraperitoneally injected in 
two mice. Their parasitaemia was daily assessed and once it reached near 0.1%, their blood was 
collected and diluted to inject half of a parasite per mice in approximately 15 mice. The parasite 
populations that emerged after cloning (clonal populations) were allowed to grow and once 
parasitaemia was near 5%, the blood was collected by cardiac puncture for storage and genotype 
analysis of parasites. 
5. Genotypic analysis of mutant parasites 
The genotype of parasites was verified by PCR and Southern blot analysis (Ménard & Janse, 1997). 
The parental populations (PPs), transfer populations (TPs) and clonal populations (CPs) that emerged 
after transfection of wt parasites with the maebl, trap or trapctd- targeting constructs will be 
hereinafter referred to as MAEBL-, cTRAP or TRAPctd- PPs, TPs and CPs. 
a. Genotypic analysis by PCR 
The PCR screening of the recombinant locus of parasites was performed using a high-fidelity DNA 
polymerase (Phusion®, New England Biolabs). Thus, the general thermocycling conditions used were 
as follows: initial denaturation step (30 seconds at 98°C), 35 cycles of denaturation (10 seconds at 
98°C), annealing (30 seconds at appropriate annealing temperature) and elongation (at least 30 
seconds at 72°C) and a final elongation step (10 minutes at 72°C).  
A portion of a non-related gene was amplified as a positive control for the PCR reactions. The 
reactions were accomplished using the primer pairs P9/P10, P23/P24 or P5/6, yielding specific 
products corresponding to portions of the trsp (PBANKA_0209100) ORF, p38 (PBANKA_1107600) or 
maebl ORF, respectively. These reactions were performed using an annealing temperature of 65°C, 
71°C or 60°C.  
Furthermore, the eventual absence of the maebl ORF in the genome of transgenic parasites was 
also assessed using the primer pair P5/P6. When necessary, a central portion of the tgdhfr ORF was 
amplified using the primer pair P17/P18 at a temperature of annealing of 58°C. 
The primer pair P7/P8 was used to verify whether the selectable marker was inserted in the 
expected site of the maebl recombinant loci of MAEBL- PPs, TPs and CPs, since P7 is complementary 
to a specific sequence of the selectable marker cassette and P8 binds at a region of the 3’UTR in the 
locus. This reaction was accomplished by using a temperature of annealing of 60°C. A similar analysis 
of the trap recombinant loci of cTRAP and TRAPctd- PPs, TPS and CPs was performed, but using the 
primer pairs P19/P20 or P22/P20, respectively. In specific, whereas P19 and P22 are complementary 
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to the terminal end of pORF or pORFctd-, respectively, P20 is complementary to a region of the 3’UTR 
in the locus; all those primers annealed at 63°C.  
Finally, using the TaKaRa Ex Taq DNA polymerase (Takara) and the primer pair P13/P14 it was 
possible to confirm the absence of a non-truncated trap ORF in the genome of TRAPctd- CPs, since P14 
is complementary to the terminal nucleotides of the endogenous trap ORF (see PCR conditions in the 
“Construction of transfection vectors” subsection). 
All reaction product ran on 1% agarose gel with ethidium bromide and images were digitally 
acquired using a UV transilluminator. 
b. Genotypic analysis by Southern blot 
gDNA (2 to 10 µg) of cloned parasites  was digested overnight at 37°C with HindIII-HF and NruI-HF 
for maebl knockouts or ClaI and HindIII-HF for cTRAP and TRAPctd- and then separated by 0.8% 
agarose gel electrophoresis at 30V for 7 hours. Under gentle agitation, the gel was depurated (0.25M 
HCl) for 15 minutes, denatured (1.5M NaCl, 0.5M NaOH ) for 30 minutes and neutralized twice (3M 
NaCl, 0.5M Tris-HC  pH 7.0) for 15 minutes, taking care of rinsing the gel with deionized water 
between incubations. The gDNA was transferred to a Nytran-N membrane (Amersham Hybond N+, 
GE Healthcare) overnight, using sodium saline citrate 10x (0.3M Sodium Citrate, 1M NaCl) as transfer 
buffer. gDNA was fixed to the membrane by incubation at 65°C for 5 hours and then revealed by 
staining the membrane in methylene blue [0.02% (w/v) Methylene blue, 0.3mM NaOAc] for 10 to 15 
minutes at RT. The hybridization probes were obtained by PCR amplification of gDNA using primer 
pairs P1/P2 and P11/12, yielding maebl and trap 5’UTR, respectively (see PCR conditions in the 
“Construction of transfection vectors” subsection). These probes were then labelled using AlkPhos 
Direct™ kit (GE Healthcare) according to manufacturer’s instructions: i.e. the amplified gDNA was 
denatured by heating at 100°C for 5 minutes, mixed with reaction buffer and alkaline phosphatase 
and cross-linked with the enzyme using a formaldehyde-containing solution by incubation at 37°C for 
30 minutes. The membrane was pre-incubated with hybridization buffer (0.25 ml per cm2 of 
membrane) at 45°C for 2 hours and then hybridized with the respective labelled probe (5 ng of probe 
per ml of hybridization buffer) overnight at the same temperature, under gentle agitation. Then, the 
membrane was washed twice in preheated primary wash buffer [2M Urea, 0.1% (w/v) SDS, 50 mM 
NaH2PO4 pH 7.0, 150 mM NaCl2,1 mM MgCl2, 0.2% (w/v) Blocking reagent, provided by the kit] for 10 
minutes at 45°C and then washed twice with secondary wash buffer (50 mM Tris:HCl, 100 mM NaCl, 
2mM MgCl2) for 5 minutes at RT. Labelled bands were visualized using CDP-Star detecting reagent (30 
µl per cm2 of membrane) and were digitally acquired in a ChemiDoc Imaging System (Bio-Rad 
Laboratories) after 1 hour exposure.  
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Section III – In vivo analysis of mutant sporozoite infectivity and capacity to 
target the liver 
Control (wt) and mutant sporozoites (MAEBL- clones B2 and G3, cTRAP clone B2 and TRAPctd- clone 
9) were collected from the salivary glands or hemolymph of mosquitoes 19 to 20 days after the 
infectious blood meal. Sporozoites were counted and intravenously injected into young C57BL/6 mice 
previously treated or not with clodronate liposomes (Tavares et al., 2013).  
Mice were imaged according to Ploemen and colleagues, 2009, using an IVIS LUMINA LT (Perkin 
Elmer), at multiple time points depending on the assay, i.e. at 7 minutes to evaluate the sporozoites 
capacity to home to the liver or 24 or 44/46 hours post-infection to evaluate infectivity. In brief, 
animals were placed in the induction chamber and anaesthesia was induced with 2% isoflurane in 
100% oxygen mixture (Tseng et al., 2015). Once anaesthetized, the chest and abdominal region of 
mice were depilated and 2.1 mg of D-luciferin dissolved in PBS was injected subcutaneously. The 
animals were placed on the sample stage of the IVIS system and after an incubation period of 5 
minutes, the bioluminescent signal was collected during 5 minutes. A non-infected mouse was always 
imaged in parallel in order to evaluate background noise signal. Mice were kept anesthetized during 
the acquisitions. 
Bioluminescence quantitative analysis and image processing were performed using the Living 
Image® 4.4 software. The region of interest (ROI) was set either to measure the entire body of the 
animal or the abdominal area at the region of the liver and measurements were expressed as total 
flux (photon per second) or average radiance (photon per second per cm2 per sr).The capacity of 
sporozoites to arrest in the hepatic sinusoids, expressed as percentage of bioluminescence in the liver 
of infected mice 7 minutes after their infection, was calculated by dividing the bioluminescent signal 
from the liver by the signal obtained from the animals’ total body surface. Sporozoite infectivity was 
inferred from the parasite loads in the liver of mice at 24 and 44/46 hours post-infection, which in 
turns correlate with the intensity of the bioluminescent signal restricted to that organ.   
Section IV – In vitro analysis of sporozoite infectivity, development and cell 
traversal 
1. Host cells and parasites 
HepG2 cells (ATCC) were cultured in Dulbecco's modified eagle medium, 4.5 g/L Glucose, 25mM 
HEPES supplemented with 10% FBS and 2mM L-glutamine, henceforth called complete medium, at 
37°C, 5% CO2 (Sinnis et al., 2013). Cells were sub-cultivated and maintained following ATCC 
instructions (American Type Culture Collection, 2016).  
For the in vitro assays, control (wt) and mutant sporozoites were collected from the salivary glands 
or hemolymph of A. stephensi mosquitoes 19 to 20 days after the infectious blood meal. The mutant 
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parasite populations used to assess the invasion capacity of maebl KO sporozoites were clone B2 and 
G3, whereas their cell traversal capacity was assessed using solely clone B2.  
2. Quantification of sporozoite invasion and development by immunofluorescence 
microscopy 
The protocols used to assess sporozoite invasion and development were adapted from the one 
described by Sinnis and colleagues, 2013. In brief, HepG2 cells were seeded in a Lab-Tek 8-chamber 
slides at 0.8 to 1x105 cells per well in 200 µl complete medium. Following an incubation period of 24 
hours at 37°C under 5% CO2, the medium was removed and 1.5 to 2x104 sporozoites in 200 µl 
complete medium were added to each well. The slides were centrifuged at 300g for 5 minutes and 
then incubated for 2 or 48 hours at 37°C under 5% CO2 for assessing invasion or development, 
respectively. The cells were then washed with warm PBS and fixed with 4% (v/v) paraformaldehyde 
(PFA) in PBS for 30 minutes at RT and stored at 4°C.  
To quantify the percentage of sporozoites that invaded HepG2 cells the slides were blocked with 
5% (v/v) FBS in PBS, henceforth named blocking solution, for 30 minutes at RT, and then stained using 
a double-staining strategy (Rénia et al., 1988). In brief, the surface of extracellular sporozoites was 
probed with mouse α-CSP monoclonal antibodies (3D11; 2 µg/ml) followed by Alexa Fluor® 568 
conjugated α-mouse IgG secondary antibodies (1:500). Slides were permeabilized with 1% (v/v) Triton 
X-100 in PBS for 4 minutes at RT, allowing the probing of intracellular sporozoites with mouse α-CSP 
antibodies (3D11; 2 µg/ml), which were revealed by Alexa Fluor® 488 conjugated α-mouse IgG  
(1:500) secondary antibodies. To assess the development, slides were sequentially blocked and 
permeabilized and then labelled with mouse α-CSP (3D11; 2 µg/ml) and rabbit α-GFP primary 
antibodies (1:250), which were revealed using Alexa 568® conjugated α-mouse IgG (1:500) and Alexa 
Fluor® 488 conjugated α-rabbit IgG (1:500) antibodies. Moreover, the DNA was labelled with DAPI 
(1:5000) in PBS. Slides were mounted in Vectashield® (Vector Laboratories) and stored at 4°C 
protected from light. 
Immunofluorescence of slides was observed using a upright epifluorescence microscope. For the 
analysis of sporozoite invasion, randomly images were acquired based on the number of host cells 
nuclei per optical field (usually, containing 200 to 500 nuclei), using a 20x objective and the Alexa 
Fluor® 488 (green), Alexa Fluor® 568 (red) and DAPI (blue) filter sets. In brief, extracellular sporozoites 
appeared using both red and green filters, whereas intracellular sporozoites could only be seen using 
the green filter. The number of extracellular, intracellular and host cells nuclei were counted in 
duplicate in approximately 10 to 30 fields and the sporozoite invasion capacity, expressed in 
percentage of infected host cells, was calculated by dividing the total number of intracellular 
sporozoites by the total number of host cells nuclei. For the analysis of EEF development, the number 
of EEFs were counted in duplicate by performing a visual scan of the whole well using a 20x objective 
and the red and green filters. To quantify the size of EEFs, 15 random pictures were acquired per each 
tested condition, using a 20x objective and the red and green filters. Moreover, representative 
pictures of each tested condition were taken using a 63x oil immersion objective using all filter sets. 
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Image processing and quantifications were performed using ImageJ (Schneider et al., 2012); 
specifically, the oval and the polygonal selection tools were used to delimit EEFs as ROI in order to 
measure the area (µm2) of parasites. 
3. Quantification of sporozoite host cell traversal by flow cytometry 
Host cell traversal capacity of sporozoites was assessed using the flow cytometry-based method 
described by Formaglio and colleagues, 2014. In brief, HepG2 cells were seed on 96 well plate at 
5x104 cell per well in 300 µl complete medium, and incubated overnight at 37°C under 5% CO2. Then 
1.5x104 sporozoites were incubated with cells in 100 µl complete medium with 5 µg/ml of propidium 
iodide (PI), for 90 minutes at 37°C under 5% CO2. Non-infected cells, i.e. cells incubated only with PI, 
were used as control. Cells were then washed twice with PBS and then trypsinized. The supernatant 
was discarded and cells were resuspended in 1% (v/v) FBS in PBS. Cells were analysed in a FACS Canto 
II flow cytometer (BD Biosciences) and data analysed using FlowJo software (TreeStar, Inc.). The 
sporozoite cell wounding capacity was assessed by quantifying the percentage of PI positive events. 
Section V – Statistical analysis 
Statistical analysis was performed using GraphPad Prism 6 software. An unpaired two-tailed 
Student’s t-test assuming equal variance was used to compare the mean of two different groups and 
an one-way ANOVA with post-hoc testing analysis (Turkey’s test) was performed to compare the 
means of three or more unmatched groups. Statistical significance was found when p<0.05. 
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During this work, two genes, maebl and trap, were targeted in GFP-luciferase P. berghei parasites 
aiming at generating maebl knockouts and TRAPctd-  transgenic parasites to explore their involvement 
in the arrest of sporozoites in the liver sinusoids. Therefore, the results are divided into two sections, 
each one related to the gene that was targeted.  
Section I – Apical membrane antigen/erythrocyte binding-like protein 
1. Generating maebl knockout parasites 
A targeted gene replacement strategy by double crossover homologous recombination was used 
for the deletion of maebl from the GFP-luciferase P. berghei parasites genome (Fig.11A-B). For that 
maebl UTRs immediately up and downstream the coding sequence were amplified by PCR using gDNA 
as template, and then cloned in the pL0001 vector (MR4) allowing the construction of the plasmid 
p∆MAEBL which contains the pyrimethamine-resistant T. gondii dihydrofolate reductase–thymidylate 
synthase (tgdhfr-ts) selectable marker flanked by the amplified DNA fragments. The p∆MAEBL vector 
was verified upon digestion with specific restriction enzymes (Fig.11C). The targeting construct 
(p∆MAEBL) was linearized following digestion with KpnI and BamHI (Fig.11A,C) and then used for 
transfection. After two rounds of pyrimethamine selection, the parental and transfer parasite 
populations were obtained and their genome analysed by PCR to verify the successful integration of 
the selectable marker in the respective chromosome locus and the eventual absence of maebl ORF 
(Fig. 12A-D). By PCR, all the parental and transfer populations were positive for the integration of the 
selectable marker and the transfer population 1 selected for subsequent cloning. The cloning 
efficiency was 25%, meaning only 4 animals out of 16 became infected, yielding the clonal 
populations B2, B3, G3 and R5. PCR analysis revealed that only B2, B3 and G3 clones were positive for 
the selectable marker integration and negative for the maebl ORF (Fig.12C-D). Their genotype was 
further analysed by Southern blot and no evidence of wt maebl locus was found in these clones 
confirming the generation of maebl knockouts (Fig.12E).  
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Figure 11– Targeted deletion of maebl in P. berghei. A, Schematic diagram of the strategy to delete maebl in P. berghei by 
double crossover homologous recombination. The maebl UTR’s sequences were amplified by PCR (light grey boxes) and 
subcloned into the plasmid, pL0001 (MR4) to generate the P∆MAEBL vector. P∆MAEBL was digested with KpnI and BamHI to 
obtain the linearized transfection construct composed by the selectable marker cassette (white arrow box) flanked by the 
maebl UTRs. B, Restriction strategy used for the construction of the targeting vector. Asterisks (*) and crosses (†) depict the 
length of the homology regions in the wt locus and the fragments that were integrated (maebl UTRs; selectable marker 
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cassette, white box) in the recombinant locus, respectively. The length of the endogenous ORF (black box) is also depicted in 
the restriction map, as well as the primer pairs (horizontal black arrows, P1-P4; sequences in Table I) used to amplify the 
maebl UTRs. C, Digestion of p∆MAEBL plasmid using the respective restriction enzymes. Digestion products were run on 1% 
agarose gel containing ethidium bromide. MW, molecular weight. 
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Figure 12- Genotypic analysis of MAEBL mutants.  A. Schematic diagram of the wt and recombinant loci. Horizontal arrows 
(P5-P8) depict the primer pairs (sequence in Table I) used in the genotypic screening of mutants by PCR. The Southern blot 
approach is also schematized: vertical arrows show the cleavage site of restriction enzymes, whereas solid bars represent 
the probe used in the analysis. The length of the expected PCR products and fragments upon digestion of gDNA with HindIII 
and NruI, is also shown in the diagram. B-D. Genotypic analysis of mutants by PCR. A portion of the ORF from a non-related 
gene, the trsp (600 bp) was amplified as a positive control for the PCR reaction (panel B). The presence or absence of the 
maebl ORF in recombinant loci of mutants was assessed using the primer pair P5/P6 (panel C). In addition, in order to verify 
the correct integration of the selectable marker cassette in their recombinant loci, mutants were screen using the primers 
P7 and P8, as they bind to the 3’ terminal end of the selectable marker cassette and at 3’ of the maebl 3’UTR, respectively 
(panel D). The latter PCR was performed using different amounts of gDNA: 25 ng (a), 50 ng (b) and 100 ng (c). In every 
reaction, gDNA of wt parasites (WT) was used as control (panels B-D). Additionally, gDNA of transfer population 1 (TP1) was 
used as an additional control in the maebl ORF PCR analysis of MAEBL- clones (panel C). PP, parental population; TP, transfer 
population; H2O, blank; MW, molecular weight. E. Genomic Southern blot analysis of MAEBL- clones (B2, B3 and G3), upon 
double digestion with HindIII and NruI and probed with the maebl 5’UTR probe. gDNA of wt parasites  (WT) was included as 
a control. MW, molecular weight. 
2. MAEBL- sporozoites are defective in invading the mosquito salivary glands 
The successful generation of MAEBL- parasites implies that MAEBL is not essential for the growth 
and development of the blood-stage parasite forms, which is in agreement with previous gene-
targeting studies (Kariu et al., 2002). To investigate the development of MAEBL- parasites in the 
invertebrate host, anopheline mosquitoes were allowed to feed on mice infected with MAEBL- clones 
B2 or G3. Approximately 19 or 21 days after the infectious blood meal, mosquitoes were dissected 
and the number of sporozoites in their midgut, hemolymph and salivary glands determined. As 
expected, the number of sporozoites associated with the mosquito salivary glands was severely 
reduced for MAEBL- when compared to the wt (Fig.13). While MAEBL- sporozoites tend to accumulate 
in the hemolymph, no differences in the numbers of sporozoites in the midguts were found, 
suggesting MAEBL- have no defects in sporozoites development and egress from oocysts (Fig.13). All 
of these findings are in agreement with the phenotype of MAEBL- sporozoites reported by Kauri and 
colleagues, 2002 (Kariu et al., 2002). Due to the strong defect of MAEBL- on the invasion of mosquito 
salivary glands, all the sporozoites used in further experiments were collected from the hemolymph.  
Figure 13- MAEBL- sporozoites cannot infect the mosquito salivary glands. A. stephensi mosquitoes were allowed to feed 
on mice infected with wt or MAEBL- blood-stage parasites. Mosquitoes were dissected 19 or 21 days after the infectious 
blood meal and sporozoites collected from mosquito midgut (MG), hemolymph (HEM) and salivary gland (SG) were counted. 
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The graphic shows two independent experiments, separated by a dashed horizontal line, concerning two different MAEBL- 
clones (MAEBL- B2, MAEBL- G3). The values correspond to the number of sporozoites collected per mosquito and are 
representative of 4 and 3 experiments, concerning the clone B2 and clone G3, respectively.  
  
3. MAEBL- sporozoites have a defective capacity to infect the liver 
To assess whether MAEBL- sporozoites infect the mammalian host in the same extent as the wt, 
5x104 sporozoites were i.v. injected into young C57BL/6 mice. The parasite burden in the liver was 
determined at 24 and 44 hours post-infection using whole mice live imaging to measure the 
bioluminescent signal following the injection of luciferin. Surprisingly, 24 hours after sporozoite 
inoculation, mice infected with mutant sporozoites had a significant lower parasite burden in the liver 
than the control group (Fig.14A). As expected, this difference was also found at 44 hours (Fig.14B). 
The fold-difference between the mean values of bioluminescence in the liver of mice infected with 
MAEBL- or WT parasites calculated at both 24 and 44 hours were highly comparable (fold-differences 
of ≈7), suggesting that the impaired infectivity of MAEBL- sporozoites might be due to a defect in the 
establishment of the liver infection rather than in the hepatic development of parasites. Only 3 mice 
out of 4 infected with MAEBL- sporozoites became infected in the blood presenting a 1-day delay in 
the prepatent period compared to control group (Fig.14C). Since each day of delay is correlated with 
a 10-fold decrease in the initial asexual-stages inoculum (Haussig et al., 2011), our results suggest that 
MAEBL- sporozoites were 10 fold less infectious than wt sporozoites. The mean parasitaemia differed 
significantly between groups over time, but despite those differences, MAEBL- blood-stages showed a 
normal asexual growth kinetics compared to wt parasites as evidenced by the similar slope of the 
curves, thus reinforcing a dispensable role for MAEBL during this phase of the parasite life cycle 
(Fig.14C). 
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Figure 14– MAEBL- sporozoites have an impaired capacity to infect the liver. C57BL/6 mice were i.v. infected with 5x104 
MAEBL- B2 (MAEBL- B2) or wt sporozoites, collected from the hemolymph 19 days after mosquito infection. A-B. The 
infectivity of mutant sporozoites was assessed by quantification of the parasite burden in the liver at 24 h (panel A) and 44 h 
(panel B) post-infection. The liver load was assessed by whole mice bioluminescence imaging, using an IVIS LUMINA LT upon 
s.c. injection of 2.1 mg of luciferin. The graphs show the values correspondent to the mean ± SD of the average radiance of 
bioluminescent signal (photons/second/cm2/sr) in the liver of 3 to 4 mice. The background levels of bioluminescence 
calculated from non-infected mice (dotted horizontal lines) are also represented. C. The parasitaemia of infected animals 
starting at day 4 post-infection (square: wt; circles: MAEBL-) was determined daily by a Giemsa-stained blood smear. 
Importantly, only 3 from 4 mice infected with mutant sporozoites became blood-stage positive. The values depicted in the 
graph represent the mean percentage ± SD of parasitaemia in logarithmic scale. Statistical analysis was performed with an 
unpaired two-tail Student´s t-test: *, p < 0.05; **, p< 0.01; ***, p< 0.001. 
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4. MAEBL- sporozoites do not home to the liver as control sporozoites 
To infect the mammalian host, sporozoites need to arrest in the liver sinusoids. In fact, once inside 
the circulatory system of the host, sporozoites rapidly target the liver, suggesting that this event is 
mediated by specific interactions between sporozoite surface proteins and host molecules (Frevert et 
al., 2005). To evaluate whether MAEBL- sporozoites home to the liver as control sporozoites we have 
performed the homing assay. For that, Kupffer cells of C57BL/6 mice were first depleted by i.v. 
injection of clodronate liposomes two days before performing the assay (Tavares et al., 2013). 
Approximately 1.3x105 MAEBL- and control sporozoites collected from mosquito hemolymph at day 
19 were i.v. injected in mice and imaged 7 minutes after using a whole mice live imaging system to 
quantify the bioluminescent signal in the liver over the total body (Fig.15A). A non-infected mouse 
injected with luciferin was included to evaluate the background signal. The percentage of 
bioluminescent signal in the liver was found to be significantly lower in mice injected with MAEBL- 
sporozoites than the control, suggesting that MAEBL might be involved on the arrest of sporozoites in 
the sinusoids (Fig.15A). The progression of the hepatic infection was monitored at 24 (Fig.15B) and 46 
hours (Fig.15C) using bioluminescence imaging. As expected, mice infected with MAEBL- sporozoites 
present a reduced liver load at both 24 and 46 hours compared to mice infected with control 
sporozoites (Fig.15B-C) resulting in a two-days delay in the prepatent period of mutant parasites 
(Fig.15D). No difference was seen in the progression of the blood-stage between mutant and wt 
parasites (Fig.15D). It is noteworthy to mention, that the lack of statistical significance (Fig.15B-C) 
might be due to the reduced number of animals per group, a limitation associated at this type of 
assay, in particular, when it has to be performed with sporozoites collected from hemolymph.  
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Figure 15– MAEBL- sporozoites cannot properly arrest in the mammalian liver. Imaging the in vivo arrest of MAEBL- 
sporozoites and monitoring the progress of liver and blood infection. A-C. The bioluminescent signal in clodronate treated 
mice and i.v. injected with 1.3x105 MAEBL- (MAEBL- G3; n=2) or wt sporozoites (wthemo; n=2), collected at day 19 from 
mosquitoes hemolymph and measured at 7 min (panel A), 24 h (panel B) and 46 h (panel C) post-infection by whole mice 
imaging using an IVIS LUMINA LT and upon s.c. injection of 2.1 mg of luciferin. In A the graph shows the mean percentage 
bioluminescent signal in the liver (%) ± SD, calculated by dividing the total flux (photons/second) in the liver by the total flux 
(photons/second) from the animals’ total body surface previously subtracted by the respective background calculated from 
non-infected mice. The graphs shown in B and C depict the mean average radiance of bioluminescence 
(photons/second/cm2/sr) ± SD in the liver of mice at 24 h and 46 h after sporozoite inoculation, respectively. The 
background values of bioluminescence are represented as a dotted horizontal line. D. Parasitaemia developed by mice 
infected with wt hemolymph (square) or MAEBL- G3 (circle) sporozoites, over time. The values correspond to the mean 
percentage ± SD of parasitaemia in logarithmic scale. Statistical analysis was performed with an unpaired two-tail Student´s 
t-test:**, p < 0.01; ns, non-significant. 
5. MAEBL- sporozoites are defective in wounding and invading HepG2 cells in vitro 
To better dissect the defective phenotype of MAEBL- sporozoites in infecting the liver, we 
performed in vitro assays to evaluate the ability of sporozoites to invade and develop inside host 
cells. For that, MAEBL- sporozoites from mosquito’s hemolymph and the respective wt control 
collected from either hemolymph or salivary glands, were incubated with the hepatoma cell line 
HepG2, during two hours at 37°C. The cells were then washed and either fixed or left in culture for 
two additional days to evaluate respectively parasites invasion or development. To determine the 
percentage of cells invaded by sporozoites we used a double labelling technique to distinguish 
between intracellular and extracellular parasites (Rénia et al., 1988). Based on that, MAEBL- showed a 
clear defect in invading HepG2 cells when compared to wt (hemolymph) sporozoites as determined in 
two independent experiments carried out for each of the two clones (Fig.16A). Additionally, we also 
observed that wt hemolymph sporozoites displayed a 5 to 14-fold decrease in invasion compared 
with wt salivary gland sporozoites (Fig.16A). As expected, an approximately 10 to 30-fold reduction in 
the number of EEFs formed by mutant sporozoites compared to the wt hemolymph sporozoites was 
observed (Fig.16B). This difference is correlated with the reduced percentage of mutant sporozoites 
capable of invading HepG2 cells (Fig.16A). Additionally, the number of EEFs formed by wt hemolymph 
sporozoites was approximately 15 to 30-fold lower than the number formed by wt salivary gland 
sporozoites (Fig.16B). Moreover, no differences were seen in the size of the few EEFs formed by 
MAEBL- compared to wt, suggesting that MAEBL is not necessary for liver-stage development 
(Fig.16B).  
 
It is well known that sporozoites display an aggressive host cell wounding/traversal behaviour 
particularly important for their progression in the skin and in the liver (Amino et al., 2008; Tavares et 
al., 2013). Although not essential for the establishment of the infection (Ishino et al., 2004; 2005a), 
cell traversal is an important mechanism used by sporozoites either to avoid clearance by Kupffer 
cells or to cross the liver sinusoidal barrier (Tavares et al., 2013). To evaluate MAEBL- sporozoites host 
cell wounding/traversal capacity, HepG2 cells were incubated for 90 min at 37°C with parasites in the 
presence of PI (Formaglio et al., 2014).  The percentage of wounded/traversed cells was determined 
by the quantification of PI positive cells by fluorescence-activated cell sorting (FACS) analysis (Fig. 
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16C). The percentage of PI+ HepG2 cells after incubation with MAEBL- sporozoites was significant 
lower than the control with wt hemolymph sporozoites (Fig.16C). Indeed, the percentage of PI+ cells 
after contact with MAEBL- sporozoites was similar to the condition of cells only (Fig.16C). In addition, 
we also found that wt hemolymph sporozoites display a significant reduction in their CT activity 
compared to the wt salivary glands sporozoites (Fig.16C).  
 
Altogether these results indicate that the defective infectivity of MAEBL- sporozoites is invasion 
and cell traversal-related. However, we cannot ignore that the impaired capacity of these sporozoites 
to recognize and arrest in the liver might be responsible for the downstream defects such as in 
invasion and cell traversal. Moreover, our data clearly show that hemolymph sporozoites are less 
infectious than salivary glands sporozoites, reinforcing the idea that sporozoites maturation in the 
mosquito salivary glands is required to overcome the biological challenges imposed by the 
mammalian host. 
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Figure 16– MAEBL- sporozoites cannot properly infect and wound HepG2 cells. A. Quantification of the invasion capacity of 
MAEBL- sporozoites after incubation with HepG2 cells for 2 h at 37°C, 5% CO2. The wide-field immunofluorescence (IFA) 
images show HepG2 cells infected with wt salivary glands sporozoites, depicting the double staining strategy used to 
quantify the sporozoites capacity to invade host cells: the surface of sporozoites was stained before and after 
permeabilization with Triton-X100, using mouse monoclonal anti-CSP antibody (3D11) in combination with Alexa Fluor® 568 
anti-mouse IgG or Alexa Fluor® 488 anti-mouse IgG, respectively. Thus, extracellular sporozoites could be seen as red and 
green, whereas intracellular sporozoites would appear only in green. The nuclei of cells were labelled with DAPI and appear 
in blue. The red signal was highlighted in order to make it easier to distinguish between extracellular (CSP, extra.) and 
intracellular parasites (CSP, intra.). An incomplete invasion event of a HepG2 cell by a sporozoite is also demonstrated. The 
values represented in the graphic correspond to the mean percentage (%) ± SD of invaded HepG2 cells. Two clones were 
independently tested, clone B2 (MAEBL- B2, circle) and G3 (MAEBL- G3, star) along with wt salivary glands (wtsg, triangles) 
and hemolymph (wthemo, squares) sporozoites. Scale bar, 5 µm. B. Quantification of MAEBL- EEF development, after 
incubation of sporozoites with HepG2 cells for 48 h at 37°C, 5% CO2. IFA images show HepG2 cells infected with MAEBL- B2, 
wt salivary glands (wtsg) or wt hemolymph (wthemo) parasites. Cells were permeabilized and stained with mouse anti-CSP 
monoclonal antibody (3D11) and rabbit α-GFP antibodies. Primary antibodies were revealed by the addition of Alexa Fluor® 
568 anti-mouse IgG (red) and Alexa Fluor® 488 anti-rabbit IgG (green). DNA of parasites and host cells was stained with DAPI 
and appears in blue (DAPI). The values shown in graphic on the left correspond to the average number of EEFs per well ± SD 
of duplicates. The graphic on the right shows EEFs area; the values correspond to the mean area ± SD of a randomly chosen 
sample of 15 EEFs, measured considering the CSP staining. Scale bar, 10 µm. C.  Assessment of the cell wounding capacity of 
MAEBL- sporozoites. MAEBL- B2, wt hemolymph (wthemo) or salivary glands (wtsg) sporozoites were incubated with HepG2 
cells, at a ratio of 1:2 (parasites:cells), for 90 min at 37°C, 5% CO2 in the presence of 5 μg/mL PI. The percentage of wounded 
HepG2 cells was quantified by FACS analysis of PI+ events. The values shown in the graph correspond to the mean ± SD of 
duplicates or triplicates. Statistical analysis was performed using an unpaired two-tail Student´s t-test or the one-way 
ANOVA for the comparison of the mean of two or multiple groups, respectively: *, p<0.05; **, p<0.01; ns, non-significant.   
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Section II – Thrombospondin-related adhesion protein 
1. Generating a trap mutant line lacking the cytoplasmic tail in C-terminal 
To explore the role of TRAP in mediating the arrest of sporozoites to the liver sinusoids, we have 
replaced by double crossover homologous recombination in the GFP-luciferase P. berghei the single-
copy of trap by a truncated version lacking the cytoplasmic tail in C-terminal (TRAPctd- line; Fig.17). For 
that, we started by constructing the  transfection plasmid (pCTD-) (Kappe et al., 1999). Trap UTRs and 
the truncated ORF were amplified by PCR, using gDNA as template, and then inserted into the 
transfection vector pL0001 (MR4) harbouring the selectable marker cassette (TgDHFR-TS gene) 
(Fig.17A-B).  As TRAPctd- parasites would harbour a selectable marker inserted in their chromosomic 
locus (Fig.17B), it was necessary to generate another parasite line that could act as an integration 
control (cTRAP), harbouring the selectable marker inserted in the same region as TRAPctd- parasites 
(Fig.18). Therefore, we engineered a plasmid similar to pCTD-, named pCTR, differing only in the fact 
of having the entire, instead of truncated, coding sequence of trap (Fig.18A-B). Transfection plasmids, 
pCTD- and pCTR were digested with the respective restriction enzymes and fragments with the 
expected sizes obtained (Fig.17C; Fig.18C). The linearized targeting constructs, obtained upon 
digestion of the vectors with KpnI and BamHI (Fig.17A; Fig.18A), were used for transfections.  
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Figure 17– Deletion of TRAP cytoplasmic tail domain in P. berghei. A. Schematic representation of the P. berghei trap 
targeted replacement strategy. The PCR amplified trap UTRs (3’UTR as well as the portion at 5’ of the promoter region; light 
grey boxes) and pORFctd- (trap promoter region and truncated ORF; white dotted arrow box) were subcloned into a final 
transfection plasmid, named pCTD- (pL0001, MR4). This plasmid was digested with KpnI and BamHI, in order to obtain the 
linearized transfection construct, composed by pORFctd- , the selectable marker cassette (white arrow box) and by the trap 
UTRs. The selectable marker cassette harbours the T. gondii dhfr-ts ORF along with the upstream and downstream control 
elements of P. berghei dhfr-ts, and therefore confers pyrimethamine resistance to transfectants. The endogenous promoter 
and ORF sequences (black arrow box) were targeted via double-crossover homologous recombination, using the 
endogenous 3’UTR as well as the remaining portion of the 5’UTR (dark grey boxes) as homology regions. The recombinant 
locus schematizes the expected recombination event. B. Restriction maps of wt and recombinant loci (upper and lower 
diagram, respectively). Asterisks (*) depicts the length of the regions of homology, whereas crosses (†) indicate the length of 
the integrated regions in the recombinant locus: the UTRs (3’UTR and the portion at 5’ of the promoter sequence), the 
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selectable marker cassette (white box) and the pORFctd- (white dotted box). The length of the endogenous promoter and 
ORF (black box) and the primer pairs (horizontal black arrows, P11-13; P15, P16, P21; sequences in Table I) that were used to 
amplify the integrated regions are depicted in the scheme. C. Digestion of pCTD- with the proper restriction enzymes. 
Digestion products were analysed on 1% agarose gel containing EthBr. MW, molecular weight. 
 
Figure 18– Targeted replacement of trap in P. berghei to generate the cTRAP line. A. Schematic diagram of the 
replacement strategy for trap. The PCR amplified trap UTRs (3’UTR as well as the portion at 5’ of trap promoter region; light 
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grey boxes) and pORF (trap promoter region and ORF; white dotted arrow box) were subcloned into a final transfection 
plasmid, named pCTR (pL0001, MR4). The linearized transfection construct, obtained by double digestion of pCTR with KpnI 
and BamHI, contained the pORF, the selectable marker cassette (white arrow box) and the UTRs. The selectable marker 
cassette renders transfectants resistant to pyrimethamine since it has the T. gondii dhfr-ts ORF along with the upstream and 
downstream control elements of P. berghei dhfr-ts. The trap endogenous promoter and ORF sequences (black arrow box) 
were targeted via double-crossover homologous recombination, using the endogenous 3’UTR as well as the remaining 
portion of the 5’UTR (dark grey boxes) as regions of homology. The recombinant locus is also shown in the diagram. B. 
Restriction maps of wt and recombinant loci (upper and lower diagram, respectively). Asterisks (*) depict the length of the 
homology regions in the wt locus, whereas crosses (†) indicate the length of the integrated regions in the recombinant 
locus: the UTRs (the 3’UTR and the portion at 5’ of the promoter sequence), the selectable marker cassette (white box) and 
the pORF (white dotted box). The length of the endogenous promoter region and ORF (black box), as well as the primer pairs 
(horizontal black arrows, P11-P16; sequences in Table I) that were used to amplify the integrated fragments are also 
depicted in the scheme. C. Digestion of pCTR with the proper restriction enzymes. Digestion products ran on 1% agarose gel 
with EthBr. MW, molecular weight. 
The transfection of parasites and subsequent drug selection of transfectants was performed as 
described above. In brief, transfected merozoites were injected into 2 mice, which were treated with 
pyrimethamine given in drinking water. Infected blood containing the TRAPctd- or cTRAP parental 
populations was injected into naïve mice, yielding under drug selection transfer TRAPctd- and cTRAP 
populations 1 to 4, respectively. Then, the gDNA of pyrimethamine-resistant populations was 
analysed by PCR to verify the successful integration of the replaced trap ORF in the respective 
chromosomic locus (Fig.19A-C; Fig.20A-C). Based on the PCR results (Fig.19A-C; Fig.20A-C) cTRAP 
transfer population 2 and TRAPctd- transfer population 3 were chosen for cloning by limiting dilution 
into 14 and 16 mice, respectively. Only 4 mice from each cloning procedure became blood infected, 
meaning that the cloning efficiency ranged between 25% and 29%, yielding cTRAP B2, B3, R3 and R4 
and TRAPctd- 5, 7, 9 and 11, respectively. Then, the genotype of all cTRAP clonal populations and 
TRAPctd- 9 and 11 was analysed by PCR (Fig.19A-D; Fig.20A-C). A first screening was performed to 
confirm whether the recombinant event occurred in the expected region of the chromosomic locus 
(Fig.19C; Fig.20C). Indeed, we could amplify the expected DNA fragment when using gDNA of cTRAP 
clones B2, R3 or R4 and TRAPctd- clones 9 and 11 as template, but not when using TRAP B3 (Fig.20C). 
In addition, primers capable to hybridize to the promoter region and final portion of trap coding 
sequence failed to amplify the expected DNA fragment when using gDNA of TRAPctd- 9 and 11, 
suggesting the successful replacement of trap (Fig.19D). Later, upon gDNA digestion and probing with 
an amplified DNA fragment corresponding to trap 5’UTR used in homologous recombination (Fig.19A, 
Fig.20A), we were capable to confirm by Southern blot analysis that the correct integration of the 
selectable marker in the chromosomic locus has been achieved in TRAPctd- 9 and 11 (Fig.19E) and in 
cTRAP B2, B3 and R4 (Fig.20D). All populations proved to be genetically homogenous and we found 
no evidence of wt trap locus (Fig.19E; Fig.20D). In the light of these results, cTRAP B2, B3 and R4 and 
TRAPctd- 9 and 11 were considered to be clones deserving further analysis.
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Figure 19- Genotypic analysis of TRAPctd- mutants. A. Schematic diagram of the wt and recombinant loci. Initially, a 
genotypic screening of transfectants was performed by PCR: horizontal arrows (P13, P14, P20, P22; sequences in Table I) 
depict the primer pairs used in the screening. The diagram also shows the Southern blot approach used to analyse the 
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genotype of mutants: vertical arrows and solid bars represent the cleavage site of restriction enzymes and the used probe, 
respectively. The length of the expected PCR products and fragments upon digestion of gDNA with HindIII and ClaI are also 
indicated in the scheme. B-D. Genotypic analysis of mutants by PCR. A portion of the ORF from the non-related genes, P38 
(700bp) or maebl (800bp) was amplified as a positive control for the PCR reactions (panel B). The integration of the 
truncated TRAP ORF in the recombinant loci of transfectants, was verified by PCR using the primers P22 and P20, as they 
bind to the terminal end of truncated ORF (pORFctd-) and to a region of the 3’UTR in the loci, respectively (panel C). An 
additional PCR analysis of the clones was performed using the primer pair P13/P14 to assess the absence of the full length 
trap ORF in their genome, since the reverse primer P14 binds to the terminal nucleotides of the endogenous trap ORF (panel 
D). In every reaction, gDNA of wt parasites (WT) was used as a control (panels B-D). PCR products were run on 1% agarose 
gel with EthBr. PP, parental population; TP, transfer population; H2O, blank; MW, molecular weight. E. Genomic Southern 
blot analysis of TRAPctd- clones (9 and 11), upon double digestion with HindIII and ClaI and probed with the 5’UTR probe. 
gDNA of wt parasites  (WT) was included as a control. MW, molecular weight.  
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Figure 20- Genotypic analysis of the cTRAP mutants. A. Schematic diagram of the wt and recombinant loci. First, 
transfectants were screened by PCR; horizontal arrows (P19, P20; sequences in Table I) represent the primer pair used in the 
screening. Vertical arrows and solid bars are inherent to the Southern blot approach and represent the cleavage site of 
restriction enzymes and the probe that was used, respectively. The length of the PCR products and fragments upon 
digestion of gDNA with HindIII and ClaI are also shown in the diagram. B-C. Genotypic analysis of mutants by PCR. The 
amplification of non-related genes, i.e. portions of the trsp ORF (600bp) and maebl ORF (800bp), was performed as a 
positive control for the PCR reactions (panel B). Integration on the trap loci was evaluated by using the primer pair P19 and 
P20 as they bind to the terminal end of pORF and to a region of the trap 3’UTR in the loci, respectively (panel C). In every 
reaction, gDNA of wt parasites (WT) was used as a control (panels B-C). Additionally, gDNA of transfer population 2 (TP2) 
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was used a positive control in the Integration PCR analysis of cTRAP clones (panel C). PCR products were run on 1% agarose 
gel with EthBr. PP, parental population; TP, transfer population; H2O, blank; MW, molecular weight. D, Genomic Southern 
blot analysis of cTRAP clones B2, B3 and R4, upon double digestion with HindIII and ClaI and probing with trap 5’UTR. gDNA 
of wt parasites (WT) was included as a control. MW, molecular weight. 
2. Evaluating cTRAP and TRAPctd- parasites infectivity   
According to previous studies, sporozoites with TRAP lacking a cytoplasmic tail have no defect on 
their asexual blood-stage, infect normally the mosquito midgut and form viable sporozoites that 
egress normally from oocysts when mature (Kappe et al., 1999). However, TRAPctd- sporozoites failed 
to infect the salivary glands of mosquitoes as well as the rat liver (Kappe et al., 1999). 
To assess the infectivity of mutant parasites to the anopheline vector, mosquitoes were allowed to 
feed on mice infected with wt, cTRAP (clone B2) or TRAPctd- (clone 9) erythrocytic-stages. Mosquitoes 
were dissected 20 days after the infectious blood meal and the sporozoites associated with their 
hemolymph and salivary glands were counted. Similar numbers of sporozoites were found in the 
hemolymph of mosquitoes infected with the different parasites, suggesting that cTRAP (clone B2) and 
TRAPctd- (clone 9) sporozoites can develop and egress normally from oocysts (Fig.21). In sharp 
contrast, dramatically fewer sporozoites were found in the salivary glands of mosquitoes infected 
with TRAPctd- (clone 9) compared to cTRAP (clone B2) or wt parasites (Fig.21).  
Figure 21– TRAP cytoplasmic tail is crucial for the infection of mosquito salivary glands by sporozoites. A. stephensi 
mosquitoes were allowed to fed on mice infected with wt, cTRAP (clone B2) or TRAPctd- (clone 9) erythrocytic-stages. Female 
mosquitoes were dissected 20 days after the infectious blood meal and the sporozoites collected from their hemolymph 
(HEMO) and salivary glands (SG) were quantified by microscopy. The values correspond to the mean ± SD of the number of 
sporozoites per mosquito and are representative of 2 independent experiments.  
Then, the infectivity of cTRAP (clone B2) sporozoites to the mammalian host was assessed by 
whole-body bioluminescence imaging in C57BL/6 mice at 24 (Fig.22A) and 44 hours (Fig.22B) after i.v. 
injection. As expected, mutant sporozoites were capable of infect and develop in the liver as wt 
sporozoites (Fig.22A-B). Moreover, both parasite populations induced blood-infections with similar 
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pre-patent periods (Fig.22C). In addition, we found no differences in the mean parasitaemia of 
infected mice and in the growth kinetics of asexual blood-stage parasites between groups over time 
(Fig.22C). 
Finally, we investigated whether TRAPctd- (clone 9) sporozoites were capable to infect the liver. 
Similar to the experiments using MAEBL- sporozoites, TRAPctd- sporozoites were collected from the 
mosquito hemolymph. Thus, C57BL/6 mice were infected i.v. with hemolymph TRAPctd- or cTRAP 
sporozoites and imaged at 24 (Fig.23A) and 44 hours (Fig.23B). At 24 and 44 hours, mice infected with 
TRAPctd- (clone 9) sporozoites presented a significantly lower infection in the liver compared to control 
group (Fig.23A-B). Moreover, none of the mice infected with TRAPctd- sporozoites developed a blood 
infection, in sharp contrast with the control group, which became blood-stage positive at day 3 post-
infection (Fig.23C).  
Together, these results demonstrated that TRAPctd- sporozoites have a defect to infect both the 
mosquito salivary glands and rodent liver. In addition, we confirmed that the insertion of the 
selectable marker in the TRAP locus (cTRAP) did not compromise sporozoites fitness. Therefore, these 
mutant lines can be used in further experiments aiming to explore the role of TRAP in mediating the 
arrest of sporozoites to the liver. 
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Figure 22- cTRAP sporozoites infect the liver as wt sporozoites. C57BL/6 mice were i.v. infected with 3x104 sporozoites, 
collected from mosquitoes salivary glands 20 days after the infectious blood meal. A-B. cTRAP (cTRAP clone B2) and wt 
sporozoites infectivity to the mammalian host was assessed by quantification of the parasite burden in the liver of  mice at 
24h (panel A) and 44h (panel B) after infection. The liver load was quantified by whole mice bioluminescence imaging, using 
an IVIS LUMINA LT upon s.c. injection of 2.1 mg of luciferin. Bioluminescence was measured in average radiance and is 
expressed as photons per second per cm2 per sr. The values depicted in the graphics correspond to the mean ± SD (n=3) of 
the average radiance, whereas the dotted horizontal line represents the background signal. C. Parasitaemia of infected mice 
over time. The values depicted in the graphic correspond to the mean parasitaemia ± SD in logarithmic scale. Statistical 
analysis was performed with an unpaired two-tail Student´s t-test: *, p < 0.05; ns, non-significant. 
 
Chapter III Results 
 
 
65 
 
Figure 23– The cytoplasmic tail of TRAP is essential for sporozoites infection of the liver.  C57BL/6 mice were infected i.v. 
with 3x104 TRAPctd- or cTRAP sporozoites, collected from the mosquitoes’ hemolymph 20 days after the infectious blood 
meal. A-B. The liver load was assessed by whole mice bioluminescence imaging, at 24h (panel A) and 44h  (panel B) post-
infection using an IVIS LUMINA LT upon s.c. injection of 2.1 mg of luciferin. The graphics show the mean ± SD (n=3) of the 
average radiance in the liver (photons/second/cm2/sr), as well as the background level of bioluminescence (dotted 
horizontal line). C. Progress of the blood-infection, expressed as mean parasitaemia ± SD in logarithmic scale. Importantly, 
none of the mice infected with TRAPctd- sporozoites became infected. Statistical analysis was performed with an unpaired 
two-tail Student´s t-test: *, p < 0.05; ns, non-significant. 
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Section I – Apical membrane antigen/erythrocyte binding-like protein 
1. MAEBL might be an important parasite ligand during Plasmodium pre-erythrocytic 
stage 
This study provides the first genetic evidence that MAEBL might be required for the liver infection 
by sporozoites. Indeed, we found that maebl knockout sporozoites from mosquitoes’ hemolymph 
were at least 10 fold less infectious to mice than wt (Fig.14). Moreover, the in vivo results were 
supported by the in vitro experiments, in which impairment in the sporozoites invasion and wounding 
of hepatocytes, but not in liver-stage development, was observed (Fig.16). Our findings also suggest 
that the impaired capacity of these sporozoites to recognize and arrest in the liver might be 
responsible for the downstream defects such as in invasion (Fig.15). However, some of our findings 
are in conflict with the Kariu et al. study in 2002, in which MAEBL was found to be required only for 
sporozoites invasion of the mosquito salivary glands but not to liver infection. It’s noteworthy to 
mention that in contrast to our study, the in vivo experiments were performed using midgut rather 
than hemolymph sporozoites (Kariu et al., 2002). It is known for long time that midgut sporozoites 
cannot infect the mammalian host at the same extent as hemolymph and salivary glands sporozoites 
(Vanderberg, 1975). Furthermore, it was demonstrated that midgut sporozoites are less motile than 
more mature parasite stages, such as hemolymph or salivary glands sporozoites (Hegge et al., 2009; 
Kudryashev et al., 2012; Sato et al., 2014). Indeed, several genes important for the sporozoite 
infectivity to the mammalian host are regulated during the sporozoite journey in the mosquito, which 
can justify the poor infective capacity of midgut sporozoites (Matuschewski et al., 2002b; Mikolajczak 
et al., 2008). Thus, it is possible that a potential defect in the infectivity of their maebl knockout 
sporozoites may have been missed, since midgut sporozoites, are per se, very poorly infectious to the 
rodent liver. Despite this discrepancy, our results are in agreement with the Kariu’s study concerning 
the mutant sporozoites phenotype in the invertebrate host. Moreover, we also found no differences 
in the kinetics of blood-stage replication of mutants compared to wt parasites (Kariu et al., 2002). 
Interestingly, a previous study performed by Preiser and colleagues in 2004 shows that liver stage 
development of P. yoelii parasites were inhibited from approximately 30% to 40%, when sporozoites 
were incubated with rabbit antiserum prepared against the extracellular domains of MAEBL (Preiser 
et al., 2004). However, in this study the authors only counted the number of schizonts formed 48 
hours after infection and did not evaluate sporozoite invasion capacity in the presence of MAEBL 
antisera. Thus, our results refine the previous observations reported by Preiser and colleagues, since 
we could directly demonstrate that the absence of MAEBL hinders the sporozoite invasion of 
hepatocytes (Fig.16A), resulting in a lowered number of EEFs formed compared to control conditions 
(Fig.16B). 
2. A conserved system for sporozoites recognition of distinct host cell molecules? 
Our results suggest that MAEBL may be an important ligand for the sporozoite infection of the 
mammalian host. At first glance, it is not expected that the same recognition system operate in both, 
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the mosquito salivary glands and in the liver of the mammalian host. However, as different stages or 
specie-specific adhesins allow the interaction between apicomplexan parasites and diverse host 
molecules using a conserved actin-myosin motor (Münter et al., 2009), we hypothesize that an 
analogous system is on the basis of the recognition and commitment of sporozoites invasion of 
distinct cells and hosts. In our hypothesis, MAEBL would act as a shapable adhesive molecule capable 
to interact with host molecules expressed at the surface of acinar and liver cells of the invertebrate 
and vertebrate host, respectively. Indeed, based on the literature, midgut sporozoites express 
different forms of MAEBL when compared to salivary glands. MAEBL was detected as two products 
with 90kDa and 96kDa majorly in mature midgut sporozoites and as a 240kDa in salivary gland 
sporozoites, henceforth called smaller and full-length product, respectively (Preiser et al., 2004). 
Interestingly, an independent study suggested that the smaller products are formed due to post-
translational modifications of the protein controlled in a time-dependent manner during sporozoites 
development in the oocyst (Singh et al., 2004). Specifically, the full-length product starts to be 
expressed by immature midgut sporozoites 7 days after the infection of mosquitoes. However, as 
midgut sporozoites mature, the full-length product is post-translational modified until being 
completely absent from midgut sporozoites at day 14 post mosquito infection (Singh et al., 2004). 
Thus, the smaller products appear to be representations of amino and carboxyl fragments originated 
from the post-translational modification of the protein (Preiser et al., 2004). In addition, during 
sporozoite maturation in the oocyst, the subcellular localization of MAEBL also varies. At day 15 post-
mosquito infection, MAEBL is still restricted to the apical pole of sporozoites, however, from that day 
forward, MAEBL starts to be distributed among the sporozoite surface, in agreement with the fact 
that MAEBL is required for the sporozoite infection of mosquito salivary glands (Srinivasan et al., 
2004). Once inside the salivary glands, sporozoites re-express the full-length MAEBL product spread 
over the parasite surface (Srinivasan et al., 2004; Preiser et al., 2004; Singh et al., 2004), possibly 
required for the establishment of a successful infection of the mammalian host liver. Hypothetically 
speaking, sporozoites could resort to post-translational modifications of MAEBL to refine the affinity 
of a conserved system, also composed by several others important adhesins such as TRAP and CSP, in 
order to recognize different host receptors. Thus, it would be interesting to suggest that the smaller 
products of MAEBL, expressed majorly by mature midgut sporozoites (Singh et al., 2004; Preiser et al., 
2004), and possibly by hemolymph sporozoites, may contribute for the infectivity of mosquito salivary 
glands, whereas the full-length product participates in the sporozoite infectivity of the liver. To 
explore this hypothesis, it would be interesting to first, confirm by western blot that hemolymph 
sporozoites do not express the full-length product of MAEBL and second, to assess whether 
sporozoites expressing the former product were capable to infect the mosquito salivary gland as the 
same extent as hemolymph sporozoites. Specifically, this could be tested, for example, by injecting wt 
salivary glands or hemolymph sporozoites into the hemolymph of non-infected mosquitoes and then 
determine their capacity to infect the mosquito salivary glands.  
It was previously suggested that the reduced number of maebl knockout sporozoites collected 
from the mosquito salivary glands was correlated with the sporozoite incapacity to adhere to acinar 
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cells of the mosquito salivary glands, contrarily to trap knockout sporozoites, which can form a 
trypsin-sensitive junction with those cells, to be shortly thereafter arrested due to their lack of 
motility (Sultan et al., 1997; Kariu et al., 2002). A similar phenomenon may occur during the infectivity 
of the mammalian host liver by sporozoites, i.e. maebl knockout sporozoites may not be able to 
properly adhere to host molecules specifically expressed by liver cells. Indeed, our results showed 
that MAEBL- sporozoites display an impaired capacity to home to the liver (Fig.15A), as well as 
impaired invasion and hepatocyte traversal capacity in vitro (Fig.16A,C). Altogether, these findings 
suggest that MAEBL may act as an adhesin capable to bind to molecules expressed by hepatocytes 
and thus contribute for the establishment of a successful infection in the mammalian host liver.  
In this work, we show that sporozoites use a conserved MAEBL dependent-mechanism to infect 
the salivary glands and the liver of invertebrate and vertebrate host, respectively. In addition, we 
speculate that this phenomenon might be regulated through post-translational modifications of the 
protein. In apicomplexan parasites, post-translational modification of proteins are associated with 
important processes such as gliding motility, invasion of host cells, growth and cell regulation and 
gene expression (Jortzik et al., 2011). This may acquire a particular importance in Plasmodium 
parasites due to their relatively small genome, which does not reflect the complexity of their life cycle 
(Singh et al., 2004). Although important, MAEBL will not certainly be the unique protein that 
participates in the process of sporozoite host cell recognition. Instead, we suggest that MAEBL may 
act along with other surface sporozoite proteins such as TRAP (Fig.8) and CSP (Coppi et al. 2011), for 
host cell recognition. The strong defective phenotype of maebl knockout sporozoites in both hosts 
might suggest a possible role of MAEBL as an “adapter” protein in the conserved molecular system, 
allowing the sporozoite interaction with distinct host molecules without having to completely modify 
the whole system during its journey from the vector to the mammalian host liver.  
3. Future directions  
The unexpected phenotype of MAEBL- in the mammalian host is worth to be further investigated. 
The next step is undoubtedly to complement the maebl knockout parasites, in order to confirm that 
their defective phenotype is due to the absence of MAEBL. The figure 24 depict a possible strategy to 
complement MAEBL- parasites. In brief, the complementation plasmid will be linearized under the 
maebl 5’UTR, to promote its insertion via single crossover homologous recombination in the 
recombinant loci of MAEBL- parasites. The re-insertion of maebl needs to be performed using the 
maebl 5’UTR as homology region, since this gene is transcribed together with the upstream gene, as a 
bicistronic transcript (Balu et al., 2009). To distinguish between complemented from maebl knockout 
parasites, the human dhfr (hdhfr) will be used as selectable marker, rendering transfectants resistant 
to the anti-folate drug WR99210 (Sultan et al., 2001). We expect that, once the targeting construct is 
inserted into the maebl locus, complemented parasites will be able to express MAEBL and their 
defective phenotype restored.  
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Figure 24- Genetic complementation of MAEBL- parasites. Schematic diagram showing the recombinant locus of MAEBL- 
parasites, the complementation plasmid and the expected complemented locus. The recombinant locus, containing the 
tgdhfr (light grey box) flanked by the maebl UTRs (dark grey boxes), will be targeted via single crossover homologous 
recombination using the 5’UTR as homology region and upon linearization of the complementation plasmid. The 
complementation plasmid will be engineered in order to contain the hdhfr (dotted white box), the MAEBL gene (white box) 
along with the maebl UTR’s (black boxes); the plasmid backbone is represented as a dashed line. The complemented locus 
will result from the insertion of the whole complementation plasmid in the recombinant locus of MAEBL- parasites. 
In addition, it would be interesting to clarify the controversy over the secretory organelle to which 
MAEBL is associated. Indeed, MAEBL was found to be associated with the rhoptries of P. yoelii (Kappe 
et al., 1998; Noe & Adams, 1998) and P. falciparum blood-stage parasites (Blair et al., 2002; Ghai et 
al., 2002). In addition, a punctuated immunofluorescent pattern limited to the apical pole of P. 
berghei merozoites upon their staining with anti-MAEBL antibodies also suggests that this protein is 
associated with the rhoptries of parasites (Kappe et al., 1997). Surprisingly, MAEBL was found in 
association not with the rhoptries by with the micronemes of P. berghei sporozoites (Kariu et al., 
2002). Thus, it would be interesting to find an independent evidence that MAEBL co-localizes with the 
sporozoite micronemes, using a specific micronemal marker, such as TRAP (Rennenberg et al., 2010). 
If so, the localization of MAEBL in P. berghei blood-stages would have to be assessed again, in order 
to understand if MAEBL is capable to associate with different secretory organelles in a specie or 
parasite developmental stage-dependent fashion.  
Lastly, it will be necessary to generate another mutant line capable to replace MAEBL- as control in 
further experiments aiming the assessment of the homing capacity of mutant sporozoites. Using a 
genome-wide expression screen with P. yoelii, it was discovered several genes upregulated in midgut 
sporozoites and downregulated in salivary glands sporozoites (Mikolajczak et al., 2008). Among them, 
the upregulated in oocyst sporozoites 3 (UOS3) seems to constitute a potential candidate to be used 
in future experiments, since it was proven that UOS3-null mutants are incapable to infect the 
mosquito salivary glands, but have no defect in their infectivity to the mammalian host (Mikolajczak 
et al., 2008). 
4. Significance of the study 
The findings of this study contributed to the overall knowledge about the molecular mechanisms 
that occur during host-parasite interactions in the pre-erythrocytic stage of Plasmodium life cycle. 
Indeed, we provide the first genetic evidence that in the absence of MAEBL, sporozoites have a defect 
in their capacity to target and then infect the liver. Furthermore, we hypothesize that a model based 
on the existence of a conserved system in which the post-translational modifications of MAEBL may 
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contribute for the successful sporozoite infection of both the mosquito salivary glands and the 
mammalian liver. The importance of this protein in the establishment of sporozoites liver infection, 
along with the fact of being highly immunogenic (Peng et al., 2016), renders MAEBL as a promising 
target to be included in a multivalent pre-erythrocytic-stage malaria vaccine. 
Section II - Thrombospondin-related adhesion protein 
According with previous studies, genetic modifications of the cytoplasmic tail of TRAP render 
parasites non-infectious for the mosquito salivary glands and the rodent liver (Kappe et al., 1999; 
Heiss et al., 2008). In agreement, we observed that TRAPctd- sporozoites were barely found in 
association with the mosquito salivary glands (Fig.21) and failed to infect the liver (Fig.23A-B) and 
consequently, the blood (Fig.23C). Thus, we consider that our results provide an independent 
evidence for the essentiality of TRAP cytoplasmic tail in sporozoite infectivity to the mammalian host. 
This may be particularly important since, to the best of our knowledge, this is the first study to 
analyse TRAP cytoplasmic tail mutant sporozoites phenotype in the mammalian host by real-time in 
vivo bioluminescence imaging. 
As the next step, it would be interesting to explore the defective phenotype of TRAPctd- sporozoites 
in the mammalian host, since their lack of infectivity may also be associated with a defective homing 
capacity to the liver. The absence of the C-terminal portion of the cytoplasmic tail of TRAP may lead 
to cumulative defects in sporozoites infectivity to the mammalian host if it renders sporozoites 
incapable to arrest in the liver sinusoids besides affecting their motility and invasion capacity. If so, it 
will be possible to assess the importance of gliding motility in the sporozoites homing to the liver. But 
before using TRAPctd- sporozoites in further experiments, it is imperative to firstly check if these 
mutant parasites are capable to properly express TRAP at their surface, since the phenotype of 
TRAPctd- sporozoites is undistinguishable from the phenotype of trap knockout sporozoites (Sultan et 
al., 1997).  
The homing capacity of TRAPctd- sporozoites can be easily tested using whole-body 
bioluminescence imaging of infected animal.  However, the existence of a control line is required to 
exclude the hypothesis that any detectable impairment in the homing capacity of TRAPctd- sporozoites 
is due to the presence of the selectable marker cassette in their genome. Thus, we constructed the 
cTRAP parasite line to act as an integration control. As we have shown, the insertion of the tgdhfr-ts 
gene in the trap locus does not interfere with sporozoites capacity to infect both, the invertebrate 
and the mammalian host (Fig.21; Fig.22).   
Taking in consideration these results, we conclude that the TRAPctd- and cTRAP mutant lines are 
valuable tools to be used in future experiments aiming the study of the role of TRAP as an adhesive 
molecule and/or TRAP associated-gliding motility in mediating the homing of the sporozoites to the 
liver. 
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Table I- List of primers used in this study. The table shows the primers used for the construction of 
p∆MAEBL, pCTR and pCTD-, as well as for the genotypic analysis of mutant parasites. The restriction 
sites are underlined. 
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